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There is a theory which states that if ever anyone discovers exactly what the Universe is for 
and why it is here, it will instantly disappear and be replaced by something even more bizarre and 
inexplicable. 
 
There is another which states that this has already happened. 
 
Douglas Adams  
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ACRONYMES AND ABBREVATIONS 
 
 
 
1´´  1 seconds 
2´  2 minutes 
3´-UTR 3 prime untranslated region 
5´-UTR 5 prime untranslated region 
60S  large ribosomal subunit 
80S  translation-competent ribosome 
Amp  Ampecillin 
bp   Base pair 
BPE  Bovine pituitary gland extract  
BSA   Bovine Serum Albunine 
cDNA   Complementary deoxyribonucleic acid 
Cp  Ceruloplasmin 
cpm  Counts per minute 
DAPI  4',6-Diamidino-2-phenylindol  
DEX   Dexamethasone 
DMEM-F12 Dulbecco's Modified Eagle Medium F12 
DMSO  Dimethylsulfoxid 
DNA   Deoxyribonucleic acid 
Dox  Doxicycline hyclate  
DTT  1,4-Dithiothreitol 
ECM  Extracellular matrix 
EDTA  ethylenediaminetetraacetic acid 
eIF  Eukaryotic initiation factor 
EMT   Epithelial to Mesenchymal Transition 
EpC40  EpH4 cells transformed with oncogenic Ras bearing in addition the effector loop 
mutation C40 
EpH4  Mouse mammary epithelial cells 
EpRas  Oncogenic Ras transformed EpH4 cells 
EPRS  Glutamyl-prolyl-tRNA synthase 
ER  Endoplasmic reticulum 
ERK  Extracellular signal regulated kinase 
EST  Expressed sequence tag 
FACS  Fluorescence activated cell sorting 
FCS  Foetal calf serum 
FFL  Firefly Luciferase 
GAIT  IFNγ activated inhibitor of translation 
GAPDH  Glyceraldehyde 3-phosphate dehydrogenase 
GCN4  General control protein N4 
GFP  Green fluorescing protein 
Hepes  2-(4-(2-Hydroxyethyl)- 1-piperazinyl)-ethansulfonacid 
IFNγ  Interferon γ  
IgG  Immunglobulin G 
IHC  Immunohistochemistry 
ILEI   Interleukin-like EMT inducer 
IP   Isopropterinol 
IRES  Internal ribosome entry site 
kb  Kilo base 
LB  Lysogeny broth 
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MAPK  Mitogen-activated protein kinase 
MCS  Multi cloning site 
MEK   
MET  Mesenchymal to Epithelial Transition 
miRNA  Micro ribonucleic acid 
MOPS  3 ( N-Morpholino )-propansulfonacid 
mRNA  Messenger ribonucleic Acid 
NASAP1 NS1-associated protein-1 
NP40  Nonylphenylpolyethylenglykol 40 
OD260  Optical density at 260nm 
ORF  Open reading frame 
PABP  Poly-A-binding protein  
PAGE  Polyacrylamid-Gelelektrophoresis 
PBS  Phosphate Buffered Saline 
PBST  Phosphate Buffered Saline with Tween 20 
PCR  Polymerase chain reaction 
PDK1  Pyruvate dehydrogenase kinase 1 
PFA  Paraformaldehyd 
PH  Pleckstrinno nolosy 
PI3K  Phosphatidyl-Inositol-3-Kinase 
PIP2  Phosphatidylinositol bisphosphate 
PIP3  Phosphatidylinositol (3,4,5)-trisphosphate 
PMSF Phenylmethylsulfonylfluorid 
poly(A)  Poly adenylation site 
Raf  Rapidly growing fibrosarcoma 
rcf  Relative centrifugation force 
RNA   Ribonucleic acid 
rpm  Rounds per minute 
RTK  Receptor tyrosin kinase 
SD Standard deviation 
SDS  Sodium dodecylsulfate 
SEM  Standard error of means 
TAE  Tris-acetat-EDTA 
TBS  Tris buffered saline 
TBST  Tris buffered saline with Tween 20 
TE  Tris-EDTA 
Tet-On-ILEI pcDNA4™/TO-ILEI 
TetR  pcDNA6/TR® 
TGFα  Transforming Growth Factor α  
TGFβ  Transforming Growth Factor β  
TGFβRI Transforming Growth Factor β receptor I 
TGFβRII Transforming Growth Factor β receptor II 
TOP  Terminal oligo-pyrimidine 
U  Units 
uORF  Upstream open reading frame 
UV  Ultra violet 
w/v Weight per volume 
XT  Ex Tumor cells from EpRas Tumors or TGFβ treated EpRas cells in collagen gels 
ZO  Zona occludens 
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ZUSAMMENFASSUNG 
 
 
 
Das Einwandern in fremde Gewebe ist ein entscheidender Schritt in der Entwicklung eines 
Tumors. Am Anfang dieser Entwicklung steht, dass die Zellen sich aus dem primären Tumor 
auswandern, und mit dem Blutstrom in entfernte Organe gelangen, wo sie auswandern und 
Metastasen bilden. Ein wichtiger Schritt in diesem Prozess ist, dass epitheliale sesshafte 
Krebszellen sich in fibroblastoide bewegliche Zellen umwandeln. Diese Transformation ist als 
epithelial zu mesenchymaler transformation - kurz EMT - bekannt. In diesem Zusammenhang 
spielt TGFβ eine wichtige Rolle, denn es reguliert die Expression vieler EMT Gene. ILEI wird von 
TGFβ auf translationaler Ebene hochregulier. ILEI ist ein neu gefundenes  Cytokin ähnliches 
Protein das selbsständig in der Lage ist EMT, tumorigenese und Metastasenbildung in 
epithelialen Zellen einzuleiten. Allerdings ist noch nicht viel über die Funktion von ILEI bekannt.  
 
Der übliche Weg, die Funktion von Genen in vitro zu studieren ist es, stabile Zelllinien mit 
veränderten Levels der Genexpression zu generieren. Allerdings birgt diese Vorgehensweise die 
Gefahr für clonale Effekte zu selektieren. Außerdem können primäre Effekte oft nicht von 
nachfolgenden Ereignissen unterschieden werden, da diese durch kompensatorische 
Mechanismen verdeckt werden. Die Klonierung von induzierbaren Systemen zur Manipulation der 
Genexpressions Levels kann all diese Probleme vermeiden. Zusätzlich kann man auch die zeitliche 
Abfolge zellulärer Reaktionen untersuchen nach dem An- oder Abschalten des gewünschten 
Gens. 
 
Das Ziel meiner Diplomarbeit was es, die Generierung eines induzierbaren tumorbiologischen 
Werkzeuges, um Genfunktionen in vitro zu studieren. Anschließend sollten die Auswirkungen von 
induzierter ILEI Überexpression in dem bereits sehr bekanntem EpH4 Zellsystem untersucht 
werden. Ein weiteres Ziel meiner Arbeit ist es, zu untersuchen, wie ILEI translationell von TGFβ 
reguliert wird.  
 
Das EpH4 Zellsystem war die Grundlage meiner Untersuchungen. Ich habe einen Tet-ON Klon aus 
EpH4 (nicht tumorigen), EpRas (mit Ras-V12 transformierte, tumorigene EpH4 Zellen) und EpC40 
(mit Ras-V12-C40 Mutante, welche eine weitere Punktmutation an dem effector loop C40 trägt, 
transformierte EpH4 Zellen), hergestellt. Dadurch hat man eine Serie von Zelllinien die nicht 
tumoriegene (EpH4), die tumorigen aber nicht metastatisierend (EpC40) und die metastaisierend 
(EpRas) Zellen, in denen es uns gelang, Tet-induzierbares ILEI zu exprimieren. 
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ABSTRACT 
 
 
 
Invasion and metastasis are crucial steps in tumorprogression in which tumor cells disengage 
from their primary tumor site, enter the bloodstream and migrate from there into distant 
organs to form secondary tumors. An essential step in this process is that epithelial, sessile 
cancer cells transform into fibroblastic, more mobile mesenchymal cells, termed epithelial to 
mesenchymal transition (EMT). In this context, TGFβ plays an important role. By regulating the 
expression of many genes involved in EMT. It up regulates ILEI (Interleukin-like EMT Inducer) 
acting exclusively at the level of translational control. ILEI is a novel cytokine-like protein that 
is sufficient to induce EMT, tumorigenesis and metastasis formation in epithelial cells. However, 
not much is known about its function.  
 
The common way to study gene function in vitro is to generate stable cell lines with altered 
levels of gene expression. However, these systems have the risk to select for clonal effects and 
primary effects, while primary effects of the introduced genes can not be distinguished from 
downstream events or might be masked by compensatory mechanisms.  
Choosing inducible systems for the manipulation of gene expression levels can avoid all this 
problems. In addition, this approach makes it possible to investigate the kinetics of cellular 
responses after the induction of gene over-expression or knock down. 
Although there are some inducible tumor cell lines available to study EMT, a comprehensive, 
inducible model system which would allow studying several aspects of tumor formation and 
progression.  
 
The aim of this diploma thesis is to generate a general tool for tumor biology to study gene 
function in vitro in an inducible manner. Subsequently, the ramifications of inducible ILEI in the 
established EpH4 system is to study. A second aim is of this thesis is to dissect how ILEI is 
translationally regulated by TGFβ.  
 
The EpH4 cell system, was the choice of our studies. I generated Tet-ON inducible EpH4 (mouse 
mammary epithelial cells ), EpRas (oncogenic Ras transformed EpH4 cells) and EpC40 (EpH4 cells 
transformed with oncogenic Ras bearing in addition the effector loop mutation C40) cell lines. 
Through this, there is a series of cell lines representing non-tumorigenic (EpH4), tumorigenic but 
non-metastatic (EpC40) and metastatic (EpRas) stages. We obtained cell lines from al three cell 
types, in which ILEI could be induced by Dox and started to analyse their phenotype.  
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1 INTRODUCTION 
 
 
 
1.1 Cancer as a multistep process 
 
Tumor progression associated with metastasis formation accounts for 90% of cancer deaths, 
and represents one of the prime causes of human mortality (Sporn MB, 1969). In general, cancer 
arises from a stepwise accumulation of genetic changes and progressive alterations in gene 
expression. Extensive cancer research has generated a rich and complex body of knowledge, 
revealing cancer to be a disease involving dynamic changes in the genome. This has been achieved 
by the discovery of mutations that produce oncogenes with dominant gain of function and tumor 
suppressor genes with recessive loss of function; both classes of cancer genes have been 
identified through their alteration in human and animal cancer cells.  
Several lines of evidence indicate that tumorigenesis in humans is a multistep process and that 
these steps reflect successive genetic alterations that drive the progressive transformation of 
normal human cells into highly malignant derivatives. It has been proposed that most and perhaps 
all types of human tumors share six altered capabilities of tumor cells (FIGURE 1). These are: 
self-sufficiency in growth signals, insensitivity to growth-inhibitory signals, evasion of apoptosis, 
unlimited replicative potential, constitutive angiogenesis, and tissue invasion and metastasis.  
(i) tumor cells show a greatly reduced dependence on exogenous growth factors, through 
generation of autocrine growth signals and constitutively active, mutated receptors, thereby 
becoming independent of their microenvironment.  
(ii) antigrowth signals can block proliferation by two mechanisms. Cells can be forced out of the 
active proliferative cycle into quiescence (G0) or cells can be introduced to permanently 
relinquish their proliferative potential by being induced to enter into postmitotic states. 
Incipient cancer cells must evade this signals if they are to prosper.  
(iii) the ability of tumor cells to expand is not only determent by the rate of cell proliferation 
but also by evading programmed cell death, a program that is latently present in all types of 
cells. Most cancer cells, perhaps all, are resistant to apoptotic signals.  
(iv) the uncoupling of a cell’s growth program from its environment, alone does not ensure 
limitless growth. The limited multiplication capacity of many, perhaps all cell types, an intrinsic 
cell-autonomous program relying on telomere shortening during consecutive divisions must be also 
disrupted, e.g. by constitutive expression of telomerase.  
(v) proliferating cells per se have no intrinsic ability to attract blood vessels and stimulating 
their growth. In order to progress to larger tumor sizes cancer cells must develop angiogenic 
abilities.  
(vi) at some point during development of most types of human cancer, primary tumors spawn 
pioneer cells that move out and travel to distant sites were they may found new colonies. This 
distant settlements are the cause for most cancer deaths in humans. Successful invasion and 
metastasis depends upon all five other acquired hallmarks described earlier. Invasion and 
metastasis formation utilize similar operational strategies, involving changes in the physical 
coupling of cells to their microenvironment, activation of extracellular proteases as well as 
changes in integrin expression and increase of epithelial carcinoma cells, loss of epithelial 
polarity.  
Each of these physiological changes is a novel capability acquired during tumor development and 
represents the successful breaching of multiple anticancer defence mechanism (Hanahan D, 
2000; Hahn WC, 2002). 
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FIGURE 1 │ Acquired Capabilities of Cancer (Hanahan D, 2000) 
  Most of the cancers develop a similar set of functional capabilities during their development but  
  through various mechanisms.  
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1.1.1 EMT (Epithelial to Mesenchymal Transition) 
Epithelial cells adhere to each other by specialized membrane structures in form of a tight 
monolayer and are strongly connected to the extracellular matrix (ECM). The core elements of 
the cell-cell interactions are tight junctions built up by claudin and occludin, adherens junctions 
formed by cadherins and gap junctions made from connexins. The main way that cells both bind 
to and respond to the ECM are integrins. They are part of a large family of cell adhesion 
receptors which are involved in cell-extracellular matrix and cell-cell interactions. Integrins are 
composed of long extracellular domains which adhere to their ligands, and short cytoplasmic 
domains that link the receptors to the cytoskeleton of the cell. The organization of the 
junctions as a lateral belt with localized distribution of adhesion molecules and the polarized 
organization of the actin cytoskeleton apical of the ECM defines the polarity of the epithelium. 
Based on these defined parameters, epithelial cells can only move in their plane (Berx G, 2007; 
Hugo H, 2007).  
 
Mesenchymal cells, as an opposite, form irregular structures with focal adhesions that are less 
strong than their counterparts with tight junctions. The mesenchyme has no apical-basolateral 
polarisation, but some polar organisation of their leading and tailing and during motility 
generated by a dynamic polarisation of the actin cytoskeleton along the axis of migration. Thus, 
these cells can move in all three dimensions by reorganising the actin cytoskeleton according the 
changes in the direction of migration. EMT describes the process in which epithelial cells lose 
their sessile phenotype and gain migrant features (FIGURE 2).  
 
 
FIGURE 2 │ EMT, an essential process in tumor formation. (Thiery JP, 2002) 
Epitheliod carcinoma cells undergo EMT to escape the mass and to intraversate lymph or blood 
vessels. After intravasation, the cancer cells must survive the shear forces of the circulation allowing 
their passive transport to distant organs. To create a new malignancy the cells under go MET, after 
extraversating from the blood stream.  
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EMT is associated with early embryogenesis in mammals when mesoderm and endoderm are 
formed (Thiery JP, 2006). Later in development EMT is responsible for organ and tissue 
formation. It players an important role in the regeneration process during wound healing. In a 
pathological context EMT is the reason for fibrosis and metastasis formation.  
 
Epithelial versus mesenchymal cells - beside their prominent structural morphological 
differences - have big differences in their gene expression profile as well. Some of the 
differently expressed genes can be used as good biomarkers to distinguish these two cell fates. 
One example, a typical marker for epithelial cells is E-cadherin. It is localized, as a 
transmembrane protein that is responsible for cell-cell contact in a Ca2+ dependent manner, to 
adherent junctions at the basal membrane and mediates cell-cell adhesions. E-cadherin is not (or 
only weakly) expressed in mesenchymal cells.  
Another marker for epithelial cells is ZO-1. ZO-1 is a protein which is only present on the 
cytoplasmic side of tight junctions, where it interacts with claudin, occludin as well as with the 
actin cytoskeleton provides a linkage between the actin cytoskeleton and the tight junction.  
 
Vimentin, a typical marker for mesenchymal cells, forms intermediate filaments and offers the 
cell with its dynamic nature flexibility. Vimentin plays a significant role in positioning and 
anchoring the organelles in the cytosol. Therefore, vimentin is the cytoskeletal component 
responsible for maintaining cell integrity under mechanical stress in vivo. 
 
The destruction of strong cell-cell contacts of epithelial cells has devastating consequences for 
the whole tissue. The loss of E-cadherin, is one very important step towards EMT. E-cadherin is 
a strong tumor suppressor and E-cadherin reintroduction is sufficient to partially or even 
completely revert EMT in certain cell types (Christofori G, 1999; Arias AM, 2001).  
EMT requires alterations in morphology, cellular architecture, adhesion and migration capacity. 
This complexity of changes might explain why EMT is controlled by at least six pathways (Wnt, 
TGFβ, Hedgehog, Notch, RTK and NF-κB (Huber MA, 2004)). In the situation of cancer these 
pathways and their cross talk are often deregulated and so become able to drive cells into EMT 
(Grünert S, 2003; Gotzmann J, 2004; Huber MA, 2005; Berx G, 2007; Lee JM, 2007). 
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1.1.2 TGFβ effects on cancer progression 
Transforming growth factor β (TGFβ) is an important pathway in tumor progression which can 
have both tumor suppressive and pro-oncogenic effects on tumorigenesis (FIGURE 3). It acts in 
early stages of cancer development as a tumor suppressor, but later on as a stimulant for 
invasion and tumor progression. The pro oncogenic effects of TGFβ are so significant because 
many human tumors overexpress TGFβ. In breast cancer for example, high levels of TGFβ 
correlate with the rate of disease progression (Gorsch SM, 1992; Akhurst RJ, 1999; Fujimoto K, 
2001). The TGFβ protein has been shown to induce apoptosis in several normal cell types. The 
initial events that follow receptor activation and result in growth inhibition and cell death are 
not fully understood yet (Derynck R, 2001). The cancer cells must find a way around the growth 
inhibition and cell death. One way is to decapitate the pathway with receptor-inactivating 
mutations and therefore silence autocrine TGFβ signalling. The other way is to selectively 
amputate the tumor-suppressive arm of the pathway either by mutations within the cascade or 
by inhibition caused by other altered or mutated pathways. This second mode allows cancer cells 
to extract additional benefits by embracing the TGFβ response for pro-tumorigenic purpose, 
enabling autocrine action of TGFβ to enhance EMT and metastasis. In both cases, cancer cells 
can use TGFβ to modulate the microenvironment to avert immune surveillance or to induce the 
production of protumorigenic cytokines. In the EpH4 model, (see chapter 1.6) TGFβ acts in 
autocrine fashion (Zhao J, 1995; de Caestecker MP, 2000; Elenbaas B, 2001; Joan Massagué, 
2008). Of the three TGFβs, TGFβ1 is most frequently upregulated in tumor cells and is the focus 
of most studies on the role of TGFβ in tumorigenesis (Derynck R, 2001). It also has been 
suggested that TGFβ1 elicits an epithelial to mesenchymal transition in vivo and that TGFβ3 
might be involved in maintenance of the spindle cell phenotype. The action of TGFβ1 in enhancing 
malignant progression may mimic its proposed function in modulating epithelial cell plasticity 
during embryonic development (Cui, 1996).  
 
 
FIGURE 3 │ Alternative roles of TGFβ signalling in tumor suppression and cancer progression 
(Wakefield LM, 2001) 
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1.1.3 TGFβ signalling pathways 
There are three different TGFβ isoforms, TGFβ1, TGFβ2 and TGFβ3, which are encoded by 
different genes and which all function through the similar receptor signalling systems. TGFβ is 
secreted in a latent form, which must be activated for binding to the signalling receptors 
(Wakefield LM, 2001). The signalling mechanism of TGFβ precursor through the ligand induced 
activation of a heteromeric cell-surface complex of two types of transmembrane 
serine/threonine kinase receptors, named TGFβ Receptor I (TGFβRI) and TGFβ Receptor II 
(TGFβRII). TGFβRI has been shown to transduce most known signals induced by TGFβ. TGFβRI 
binds and phosphorylates the transcription factor. Smad2 or, alternatively, its close homolog 
Smad3. In their phosphorylated form Smad2 and Smad3 associate with Smad4, enter the 
nucleus and modulate transcription of TGFβ responsive genes (Massague J, 2000; Derynck R, 
2001). Besides the Smad pathway there are several Smad independent ways how TGFβ can 
activate gene expression (FIGURE 4). 
Please note that “TGFβ” referes to TGFβ1 in my thesis.  
 
 
FIGURE 4 │ Various TGFβ signalling pathways. (Wakefield LM, 2001) 
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1.1.4 Ras effector pathways 
Ras proteins regulate cell fates by coupling receptor activation to more than 20 downstream 
effector pathways that control diverse cellular responses including proliferation, differentiation 
and survival (Repasky GA, 2004; Rajalingam K, 2006; Karnoub AE, 2008). Ras proteins are small 
GTPases that cycle between inactive, guanosine diphosphate (GDP)-bound and active, guanosine 
triphosphate (GTP)-bound conformations (FIGURE 5) (Schubbert S, 2007). In the active form Ras 
binds to the many downstream effectors and stimulates their signalling pathways.  
 
 
FIGURE 5 │ Upstream and downstream of Ras signalling. (Campbell PM, 2004) 
Stimuli from outside of the cell activate e.g. through TGFβ and other adaptor proteins guanine 
nucleotide exchange factors (GEF). GEF replaces Ras bound GDP with GTP and renders Ras therefore 
active. GTPase activating protein (GAP) triggers the hydrolysis of GTP back to GDP and so into an 
inactive form. The active GTP-bound Ras binds to the many downstream effectors and stimulates 
their signalling pathways.  
 
The PI3K cascade: 
PI3K is a heterodimer comprised of the p85 regulatory and p110 catalytic subunits (Cantley LC, 
2002). Ras can recruit and activate PI3K direct by binding to the p110 unit. At the membrane, 
PI3K phosphorylates phosphatidylinositol-4,5-bisphosphate (PIP2) and converts PIP2 into PIP3. 
Then PIP3 recruits other downstream molecules—particularly the serine-threonine kinases Akt 
and PDK1—via binding to their pleckstrinhomology (PH) domains. Akt is activated through 
phosphorylation by PDK1 at the membrane. Akt in turn regulates a wide range of target proteins 
that control cell proliferation, survival, growth, and other processes (Lawlor MA, 2003). 
 
The Ras/MEK/ERK cascade: 
Activated Ras proteins interact directly with the Raf family kinases (comprised of A-Raf, B-Raf 
and C-Raf). This interaction is the first step required for Raf activation. Strikingly, converting 
the Raf kinases from inactive into active enzymes is a highly complex process, involving 
membrane localization, cycles of phosphorylation/dephosphorylation and protein interactions. 
Once activated, all Raf family members are capable of initiating the phosphorylation cascade, 
whereby Raf activates MEK by phosphorylation, and MEK activates ERK again by phosphorylation. 
When ERK activation is achieved it phosphorylates critical targets in the cytoplasm and nucleus 
required to carry out the cellular response (McKay MM, 2007). 
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Replacing glycine 12 of Ras with any other amino acid except proline it biochemically activates 
Ras by rendering it into a constitutive GTP bound state. This constitutive active Ras-V12 mutant 
activates all the Ras effector pathways simultaneously. Additional pointmutations in the core 
effector domain of Ras (residues 32 to 40) can selectively activate specific pathways. For 
example, the T35S mutation causes loss of PI3K and Ral effector binding, but maintains the 
capability of Raf activation. In contrast, the E37G mutation causes the loss of Raf and PI3K, but 
not of Ral activation. Finally, the Y40C substitution does not impair PI3K activation, but causes 
the loss of Raf and Ral activation (FIGURE 6) (Campbell PM, 2004). Thus, the con? Of the V12 
mutation with on of the effector loop mutations in the Ras protein enables the selective study of 
the necessity of effects of different Ras effector pathways.  
 
There are several known Ras effector pathways Tiam1, PI3K, ERK/MAPK, Ral/GEF, PLCε, Rassf1 
and others. The ERK/MAPK and PI3K pathway were extensively studied in the EpH4 system and 
were the most relevant for my studies. Therefore, these will be the ones I introduce in more 
detail.  
 
 
 
FIGURE 6 │  Ras effector mutations. (Campbell PM, 2004) 
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1.1.5 Cooperative interaction of Ras and TGFβ via the ERK/MAPK and PI3K pathways 
TGFβ can activate MAPK pathways directly, and interact with the pathway when it is activated 
via other routes. There is data that suggest an activation of MAPK pathways plays an important 
role in diverting the TGFβ response towards a pro-oncogenic outcome. TGFβ and activated Ras 
cooperate to promote invasive, metastatic behaviour and induction of EMT in epithelial cells. 
This behaviour is dependent on the presence both of activated Ras and of a functional TGFβ 
autocrine loop that is enhanced by Ras (Chen RH, 1993; Oft M, 1996; Wakefield LM, 2001).  
 
The importance of the PI3K pathway for tumor cell hyperproliferation is also evident in vivo. 
EpC40 cells caused rapidly growing tumors, while ERK/MAPK-activating EpRas-V12-S35 (EpS35) 
cells caused only slow tumor growth. Nevertheless, EpS35, but not EpC40 tumor cells underwent 
TGFβ induced EMT in vivo, showed an EMT phenotype after recultivation of tumor cells and 
induced lung metastases upon tail vein injection. These results indicate that tumor cell 
dedifferentiation during EMT and tumor cell hyperproliferation are separable events, caused by 
different signal transduction pathways (Jechlinger M, 2002). A hyperactive Raf/MAPK pathway 
is required for TGFβ induced EMT, tumorigenesis, and metastasis formation. In contrast, 
activation of the PI3K pathway is required for protection from TGFβ induced apoptosis, allowing 
scattering but not EMT and causing tumors but not metastasis. Thus, EMT and metastasis are 
closely linked processes, both relying on the synergism between constitutive hyperactivation of 
the Raf/MAPK signalling module and TGFβ -R signalling (Janda E, 2002b). 
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1.1.6 The EMT model system  
In this diploma thesis all the work has been done in the EpH4 model system (FIGURE 7).  
 
 
FIGURE 7 │  The model cell system A) in vitro and B) in vivo.  
 
The EpH4 cells are well-polarized, nontumorigenic mammary epithelial cells and they are used to 
establish a model system of EMT in vitro and in vivo (Janda E, 2002b; Janda E, 2002a). In type I 
collagen gels, they form organotypic tubular structures requiring minute amounts of TGFβ 
whereas higher TGFβ, concentrations induce cell cycle arrest and apoptosis (Oft M, 1996). EpH4 
cells were derived from primary mammary gland tissue of mid-pregnant BALB/c mice by 
spontaneous immortalization (Reichmann E, 1989; Reichmann E, 1992; Fialka I, 1996). 
 
EpRas are derivatives of EpH4 cells. They were generated by the transformation of EpH4 cells 
with oncogenic Ha-Ras-V12 (FIGURE 7). They form rapidly growing tumors in mice and undergo 
EMT in response to TGFβ both in tumors and in collagen gels. Thus, Ha-Ras oncoprotein 
cooperates with endogenous TGFβ to cause EMT of mammary epithelial cells, both in vitro and 
upon tumor formation in mice. Along with the morphological changes of EpRas cells during EMT 
changes in marker expression occur as well. E-cadherin is down regulated and vimentin is up 
regulated. When cultured in type I collagen matrices in the complete absence of TGFβ, both 
nontumorigenic EpH4 cells and their counterparts EpRas develop into lumenforming, organotypic 
structures consisting of monolayers of polarized epithelial cells. In the presence of TGFβ, 
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however, EpRas cells form lumenless cords and cell strands that consist of cells exhibiting 
fibroblastoid properties. This is in contrast to EpH4 cells, which upon TGFβ treatment stop 
proliferating and undergo apoptosis. The converted, the fibroblastoid cells themselves produce 
high levels of TGFβ, but they revert to an epithelial phenotype in sparse cultures upon exposure 
to neutralizing TGFβ antibodies or TGFβR inhibitors, indicating that an autocrine TGFβ loop is 
required for the maintenance of the mesenchymal phenotype (Oft M, 1996).  
Exgrafted EpRas cells can be recultivated and are called from then on EpRasXT (ex tumor) cells. 
These EpRasXT cells are characterized by a spindle-like morphology, loss of epithelial and gain 
of mesenchymal marker proteins, a phenotype stabilized by an autocrine TGFβ loop in vitro and in 
vivo (Oft M, 1996). 
 
The third cell line is called EpC40 (FIGURE 7). They represent EpH4 cells transformed by 
mutated oncogenic Ha-Ras-V12-C40, which only signals along the PI3K pathway. They form 
strictly nonmetastatic tumors in mice and undergo scattering upon TGFβ treatment, a phenotype 
resembling partial EMT: E-cadherin still expressed at the plasma membrane, vimentin not 
induced.  
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1.1.7 Screen for EMT specific genes 
A screen to identify molecular players involved in EMT and metastasis formation has been 
performed in the laboratory of Hartmut Beug. For the Expression profiling a set of in vitro and 
in vivo model cell systems has been chosen. The basis of this screen were fully polarised 
mammary epithelial cells (EpH4) and eight closely related cell pairs (FIGURE 8). This pairs were 
modified by defined oncogenes (e.g. Ras) and/or external factors (e.g. TGFβ) so that specific 
aspects of migration, local invasion and metastasis formation could be studied. Since mRNA 
levels do not necessarily reflect protein levels in cells, an improved expression profiling method 
based on polysome-bound RNA has been used (Mikulits W, 2000). This setup was suitable to 
analyse global gene expression on Affymetrix chips. A substantial fraction of all regulated genes 
was found to be exclusively controlled at the translational level. Furthermore, profiling of the 
above multiple cell pairs allowed one to identify small numbers of genes by cluster analysis, 
specifically correlating gene expression with EMT, metastasis, scattering and/or oncogene 
function. For complete EMT and metastasis >30 genes have been found. A small set of genes 
specifically regulated during EMT was identified, including key regulators and signalling pathways 
involved in cell proliferation, epithelial polarity, survival and transdifferentiation to 
mesenchymal-like cells with invasive behaviour (Jechlinger M, 2003). In this screen, a novel gene 
was found, belonging to a small gene family (FAM3A-D) with no sequence homology to any known 
genes. It was translationally controlled in cells undergoing EMT and methastasis formation. It 
was named ILEI , Interleucin Like EMT Inducer.  
 
 
FIGURE 8 │ Cell pairs in the expression profiling screen. (Jechlinger M, 2003) 
The cell pairs employed in this screen are depicted schematically. Apical markers: red dots, 
basolateral markers: green/pink square, mesenchymal markers: red fibrils, the pictograms show also 
the in vitro observed phenotypical changes in this cells. Tumorigenic and metastatic potential was 
tested by injection in nude mice.  
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1.1.8 ILEI 
ILEI is part of a novel gene family, FAM3 (Family with sequence similarity 3). There are four 
genes in this family, FAM3A, FAM3B, FAM3C, and FAM3D, each encoding a protein of 224–235 
amino acids. The family was identified by a genome-wide screen for the identification of novel 
genes encoding proteins with a four-helix-bundle cytokine fold. Northern analysis indicates that 
FAM3B is highly expressed in pancreas, FAM3D in placenta, and FAM3A and FAM3C in almost all 
tissues  (Zhu Y, 2002), for example in the developing inner ear of the mouse (Pilipenko VV, 
2004). ILEI is equivalent with FAM3C. The four α-helices within FAM3C, however, do not 
structurally resemble the 4 helix bundle of interleukins.  
Ectopic expression of ILEI is able to induce complete EMT as determined by the loss of the 
epitial marker E-cadherin and the gain of vimentin expression (TABLE 1). The induction of EMT by 
ILEI is independent of TGFβ but depends on Ras signalling. If Ras signalling is totally abolished 
through a specific inhibitor, EMT is blocked, despite of ILEI overexpression. It is possible to 
mimic ILEI effects with recombinant ILEI. Consistent with this findings, EMT is fully reversed 
upon ILEI depletion using an anti-ILEI antibody. The way, how ILEI exactly works is unknown 
but it is sufficient to induce EMT. ILEI does not need TGFβ signalling for EMT. ILEI induced 
EMT can not be reversed by TGFβ-receptor blockage, unlike TGFβ induced EMT (Waerner T, 
2006).  
In normal tissues, ILEI localisation shows a granular patterning which might represent storage 
vesicles. In biopsies of cancer patients show that ILEI there is expressed in varying levels with 
a cytoplasmic localisation. The switch between granular and cytoplasmic ILEI localisation 
correlates with the disease free and overall survival of the patients, suggesting that ILEI might 
serve as a new diagnostic marker.  
 
Cell Line Ras Activity ILEI Expression EMT § Tumorgenisis Metastasis 
EpH4 low low - - - 
 low over-expressed + + + 
 inhibited by L739749 % over-expressed - - - 
EpC40  constitutive active & low - + - 
 + TGFβ  constitutive active & low scattering + - 
   constitutive active & over-expressed + + + 
EpRas    constitutive active low -   
 + TGFβ  constitutive active low + + + 
 + TGFβ  constitutive active inhibited by siRNA - - - 
  constitutive active over-expressed + + + 
§ As assayed by dereased E-cadherin and increased vimentin expression.  
% Specific nontoxic inhibitor of Ras-farnesylation 
& Activation only of the PI3K pathway 
TABLE 1 │ ILEI effects in the model system regarding EMT. Modified (Mackenzie NC, 2006) 
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1.1.9 Principle and strategy of the T-REx™ inducible system  
The expression of the gene of interest (ILEI) is repressed in the T-REx™ system when 
tetracycline is absent and induced in the presence of tetracycline or its derivate (doxycyclin 
short Dox) (Yao F, 1998). The T-REx™ system uses only regulatory elements from the native Tet 
opperon so that the tetracycline-regulated gene expression resembles closely the regulation of 
the native bacterial tet operon (Hillen W, 1983; Hillen W, 1994) and avoids the potentially toxic 
effects of viral transactivation domains observed in some mammalian cell lines.  
The two components of the T-REx™ system are the inducible expression plasmid pcDNA4/TO® 
(called Tet-On-ILEI vector) and the Tet-Repressor expression vector pcDNA6/TR® (called TetR 
vector).  
The gene of interest in the expression plasmid is controlled by a CMV promoter (Boshart M, 
1985; Nelson JA, 1987; Andersson S, 1989) into witch 2 copies of the tet operator 2 (TetO2) 
sequence have been inserted in tandem. The TetO2 sequences consist of 2 copies of a 19 
nucleotide sequence separated by a 2bp spacer (Hillen W, 1983; Hillen W, 1994). Each of this 
19bp TetO2 sequence serves as a binding site for the Tet Repressor homodimer.  
The second vector, the pcDNA6/TR® regulatory vector expresses high levels of the TetR gene 
(Postle K, 1984) under the control of the human CMV promoter. In the absence of Dox, the Tet 
Repressor binds with high affinity to the TetO2 sequence in the promoter of the expression 
vector and so the expression of the gene of interest is off (FIGURE 9). When doxycycline is 
added, it binds with high affinity to the TetR dimmers. This binding cause a conformational 
change and the TetR is no longer able to bind the TetO2 operator which allows the transcription 
of the gene of interest.  
 
 
 
FIGURE 9 │ Mechanism of the T-REx™ system. 
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1.2 Translational regulation of gene expression 
 
Control of gene expression is achieved at various levels, such as transcription, post-
transcriptional processing, mRNA stability, translation, post-translational modifications and 
protein degradation. (Meijer HA, 2002). In most cases, translational control mechanisms result 
from the interaction of RNA-binding proteins with 5´- or 3´-untranslated regions (UTRs) of 
mRNA. In organisms ranging from viruses to humans, protein-mediated interactions between 
transcript termini result in the formation of an RNA loop. Such RNA ‘circularization’ is thought 
to increase translational efficiency and, in addition, permits regulation (Mazumder B, 2003). 
 
1.2.1 Regulatory elements of the 5´-UTR 
The 5'-UTR is a particular section of DNA and mRNA in front of the coding sequence. It starts 
at the +1 position, and ends before the start codon (usually AUG) of the coding region. It usually 
contains a ribosome binding site and can be hundreds or more nucleotides long (FIGURE 10) 
(Lodish H, 2004). 
During protein synthesis the translational control has two major mechanisms for initiating 
translation: cap-dependent initiation and cap-independent initiation using the so called internal 
ribosome entry site (IRES).  
 
1.2.1.1 Cap dependent translation initiation: 
The 5' cap is a distinctive feature of eukaryotic mRNA. The cap consists of 7-methyl guanosine 
linked via an inverted 5'-5' triphosphate bridge to the initiating nucleoside of the transcript. A 
binary complex of eukaryotic translation initiation factor 2 (eIF2) and GTP binds to methionyl–
transfer RNA (Met–tRNAi-Met), and the ternary complex associates with the 40S ribosomal 
subunit. The association of additional factors, such as eIF3 and eIF1A , with the 40S subunit 
promotes ternary complex binding and generates a 43S pre-initiation complex. The cap-binding 
complex, which consists of eIF4E, eIF4G and eIF4A, binds to the 7-methyl-GTP (m7GTP) cap 
structure at the 5′ end of a messenger RNA (mRNA). eIF4G also binds to the poly(A)-binding 
protein (PABP), thereby bridging the 5′- and 3′-UTRs of the mRNA. This mRNA circularization 
and the ATP-dependent helicase activity of eIF4A are thought to promote the binding of the 
43S pre-initiation complex to the mRNA, which produces a 48S pre-initiation complex. Following 
scanning of the ribosome to the AUG start codon, GTP is hydrolysed by eIF2, which triggers the 
dissociation of factors from the 48S complex and allows the eIF5B- and GTP-dependent binding 
of the large, 60S ribosomal subunit. Although the precise timing and requirements for the 
release of factors from the pre-initiation complexes are not clear, the 80S product of the 
pathway is competent for translation elongation and protein synthesis (FIGURE 10 and 11a)  
(Klann E, 2004).  
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FIGURE 10 │ Pathway of cap dependent translation initiation in eukaryotes (Klann E, 2004).  
 
1.2.1.2 Cap independent translation initiation: 
IRES is a nucleotide sequence that forms strong secondary or tertiary structures (or both) and 
allows translation initiation in the middle of a mRNA sequence. The first IRES was discovered 
for cytoplasmic RNA viruses but has also been identified for DNA viruses and cellular mRNAs. 
IRES directs internal binding of ribosomes and nucleates the formation of a translation 
initiation complex (FIGURE 11b) (Semler BL, 2007). IRES mediated, cap independent, translations 
make 3-5% of all translated cellular mRNAs. Interestingly, many mRNAs that contain IRES 
encode proteins that have important roles in cell growth and proliferation, differentiation and 
the regulation of apoptosis. This is, perhaps, not surprising given that these cellular processes 
require the strict control of gene expression. IRES-mediated translation provides a means for 
escaping the global decline in protein synthesis and allows the selective translation of specific 
mRNAs. This led to the idea that the selective regulation of IRES mediated translation is 
important for the regulation of cell death and survival. As mentioned, IRES continue to function 
when cap-dependent translation is compromised. This is because IRES translation is independent 
of the presence or integrity of several canonical initiation factors (primarily eIF4E). Efficient 
IRES-dependent translation requires auxiliary cellular proteins that are known as IRES trans-
acting factors (ITAFs). Several ITAFs have been implicated in IRES-mediated translation, 
although the requirement for these proteins is not absolute and seems to be IRES specific 
(Holcik M, 2005).  
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FIGURE 11 │ Cap-dependent versus internal ribosome-entry site-dependent translation initiation 
(Holcik M, 2005).  
a) The cap-binding protein eIF4E; (blue), binds to the 5′ m7GpppN cap structure (red). The capped 
end of the mRNA is bridged to the 40S ribosomal subunit (green) by an adapter molecule eIF4G (dark 
green), which binds to eIF3 (yellow). eIF4A (cyan) is an RNA-dependent ATPase and RNA helicase, 
which is thought to be involved in the unwinding of the secondary structure of the mRNA 5′-UTR. 
PABP; (pink) circularizes the mRNA through its interaction with both the 3′-UTR (through the poly(A) 
tail) and the 5′ UTR (through the interaction with eIF4G). 
b) IRES trans-acting factors (ITAFs; orange) and proteolytic fragments of eIF4GI or 
p97/DAP5/NAT1, a distant homologue of eIF4G, (light grey) stimulate IRES translation. Only eIFs 
that are pertinent to this process are indicated, and individual components of the translation 
machinery are not drawn to scale 
 
1.2.1.3 Upstream open reading frames (uORFs): 
Upstream open reading frames locate upstream of the actual ORF in the 5´-UTR with AUG as 
start codon or alternative starts like CTG. The uORF can appear in several forms, only one or 
several after one another, they can terminate before the popper ORF or overlap with the gene. 
After translating a uORF a ribosome has five options. One option of the ribosome is it can 
remain associated with the mRNA, continue scanning, and reinitiate further downstream, at 
either a proximal or distal AUG codon (FIGURE 12 option 1 and 2). Another option is to stall 
during either the elongation or termination phase of uORF translation, creating a blockade to 
additional ribosome scanning (FIGURE 12 option 3). The uORF may effect gene expression by 
altering mRNA stability (FIGURE 12 option 4). After termination of an uORF the ribosome has 
again more options, it can remain associated with the mRNA (FIGURE 12 option 1 and 2) or it can 
dissociate (FIGURE 12 option 5) (DR Morris, 200).  
 
 
FIGURE 12 │ Alternative fates available to a ribosome after translating an uORF (DR Morris, 200).  
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1.2.1.4 Terminal oligo-pyrimidine tract (TOP) as translational regulator: 
TOP mRNAs carry a TOP adjacent to the cap structure in their 5' untranslated region. The 
oligo-pyrimidine tract probably serves as a protein binding site and this protein binding inhibits 
then translation. TOP mRNAs normally encode proteins of the translational apparatus (including 
ribosomal proteins, elongation factors and PABP) which are not translated in resting cells and 
shift into polysomes when cells are stimulated to grow. This structural motif comprises the core 
of the translational element of these mRNAs and invariably consists of a cytosine at the cap 
site, followed by an uninterrupted stretch of 4–15 pyrimidine bases.  The translational control of 
TOP mRNAs is manifested by a selective unloading of these mRNAs from polysomes 
(translational repression) when progression through the cell cycle is blocked at the G0, G1/S or 
G2/M phase and when cells are deprived of amino acids. Conversely, TOP mRNAs are recruited 
into polysomes (translational activation) when resting cells are induced to proliferate or to grow 
(increase in size), or when cells starved of amino acids are re-fed.  
 
 
 
INTRODUCTION _______________________________________________________________________________________________________________ 
________________________________________________________________________ 
29 
1.2.2 Regulatory elements of the 3´-UTR 
The three prime untranslated region (3'-UTR) is a particular section of mRNA. It follows the 
coding region and can be over 1kb long, it. Alternative poly(A) sequences and binding sequences 
for miRNAs can be found in 3´-UTRs which regulate the stability of the RNA. Strong secondary 
structures in the 3´-UTRs can act as binding sites for regulatory factors, or complexes like the 
GAIT structure. All these regulatory mechanisms are able to contribute to the over all 
translational regulation by the 3'-UTR. 
 
1.2.2.1 Micro RNAs as translational regulator: 
microRNAs (miRNAs) are predicted to control the activity of approximately 30% of all protein-
coding genes, and have been shown to participate in the regulation of almost every cellular 
process investigated so far. Most miRNAs form imperfectly complementary stem-loop 
structures, pair imperfectly with sites in the 3´-UTR of their target mRNAs, and can apparently 
act by decreasing target messenger RNA levels or by directly inhibiting translation (FIGURE 13). 
In some cases miRNAs have been proposed to act relatively promiscuously and to inhibit multiple 
targets. Many genes have predicted target sites for several different miRNAs in their 3´-UTRs, 
indicating the possibility for combinatorial action of multiple miRNAs to maximize inhibition of 
gene activity, although for most genes these predictions have not yet been tested (Boyd SD, 
2008; Filipowicz W, 2008). 
 
 
FIGURE 13 │  miRNA synthesis and function (Boyd SD, 2008). 
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1.2.2.2 Poly(A) tail as translational regulator: 
Polyadenylation is the synthesis of a poly(A) tail at the end of an RNA molecule. The poly(A) tail 
consists of a stretch of RNA where all the bases are adenines. This is part of the route in 
eukaryotes to produce mature mRNA for translation. At the end of transcription, the last bit of 
the newly made RNA is cleaved off by a complex of proteins, this complex then synthesises the 
poly(A) tail at the RNA's 3' end. Polyadenylation can result in more than one RNA variant of a 
gene (similar to alternative splicing), depending on which polyadenylation site is used for the 
gene in a particular cell. The poly(A) tail is important for the stability of mRNA, and when the 
tail is shortened the mRNA is soon enzymatically degraded by exonucleases. Roughly half of all 
protein-coding genes have more than one polyadenylation site, so a gene can code for several 
mRNAs that differ in their 3' end. For some genes there are several polyadenylation sites on 
the last exon, and for some genes they are spread over several exons. The vast majority of 
poly(A) sites are found in the 3'-UTRs, but some sites are found in introns, coding sequences and 
5'-UTRs. The different 3'-UTRs resulting from alternative polyadenylation can cause different 
regulation for different polyadenylation variants, since it can influence which binding sites for 
miRNAs the 3'-UTR contains. 
 
 
1.2.2.3 GAIT as translational regulator: 
A new mechanism of translational control was found in monocytes; it is called IFNγ activated 
inhibitor of translation (GAIT). IFNγ activates the translation of ceruloplasmin (Cp) in these 
cells but after some time the protein synthesis stops despite the presence of abundant 
transcript. This translational silencing is mediated by GAIT. The GAIT element is a structural 
element consisting of an apical loop, an asymmetric internal bulge and a distal stem (FIGURE 14). 
Beside the precise structure, the identity of two loop nucleotides (A84 and U87) are essential 
for binding activity (Ray PS, 2007).  
 
 
FIGURE 14 │ Secondary structure of human Cp GAIT element (Ray PS, 2007). 
 
In a screen using the 3´-UTR database several transcripts with GAIT element-like RNA 
structures were found for, e.g. vascular endothelial growth factor-A (VEGF-A) (Ray PS, 2007).  
 
The assembly of the GAIT complex occurs in two temporally distinct steps. During the first 
step, a pre-GAIT complex of proteins is formed that does not bind the GAIT element. In the 
second step, L13a is phosphorylated and released from the large ribosomal subunit. The released 
L13a joins GAPDH and the pre-GAIT complex to form the functional GAIT complex that binds 
the 3’-UTR GAIT element of Cp mRNA and blocks its translation by inhibiting the assembly of 
the translational initiation complex (FIGURE 15) (Kapasi P, 2007; Ray PS, 2007). 
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FIGURE 15 │ 3´-UTR bound GAIT complex represses translation (Kapasi P, 2007). 
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1.3 The ILEI mRNA 
The genomic organization of ILEI, has been performed by BLAST search, Northern blot analysis 
and RT-PCR amplification (Pilipenko VV, 2004). Two EST sequences (BC009086 and AX424275) 
were found and assembled together generating a transcript with a total length of 2738bp. 
Sequence analysis has revealed that in transcript BC009086 the polyadenylation signal sequence 
(AATAAA) is located 11bp upstream from the poly(A) tail. in transcript. The long transcript 
AX424275 also contains a polyadenylation signal sequence (ATTAAA) only 19bp upstream from 
the transcript termination, indicating that both short and long transcripts exist as mature 
mRNA. This prediction for two ILEI mRNA isoforms has been confirmed by Northern blot 
analysis (Pilipenko VV, 2004) (FIGURE 16).  
 
 
FIGURE 16 │ The genomic organisation with alternative poly(A) tail of ILEI (Pilipenko VV, 2004). 
 
The ILEI gene encompasses over approximately 50kb at chromosome 6A3.1 and has ten exons, 
nine introns. The coding region starts in exon two and ends in exon 10. The alternative poly(A) 
site in the 3´-UTR is used to generate a shorter ILEI mRNA isoforms, which encodes the same 
protein product as the long mRNA isoforms. (FIGURE 17) (Pilipenko VV, 2004). 
 
 
 
FIGURE 17 │ The genomic organisation of the mouse ILEI gene (Pilipenko VV, 2004). 
Schematic representation of the general structure of ILEI. The ILEI gene has ten exons (numbered) 
and nine introns (black bars), the coding region (light grey) starts in exon two and ends in exon 10. The 
alternative poly(A) site in the 3´-UTR is hatched. 
Predicted alternative  
Poly(A) signal 
EST 5´UTR CDS 3´UTR long p(A) 
1 131 2738 
5´UTR CDS 3´UTR short p(A) 
1 131 1370 
5´UTR CDS 3´UTR long p(A) 
1 131 2738 
-104 
BC009086 
AX424275 
NM138587 
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1.3 Aim of this work 
 
The first aim of this diploma thesis was to establish an inducible overexpressing setup in the 
EpH4 cell system in general. Secondly, our protein of interest, ILEI, was to be studied in three 
different cell lines with and without induction. Another aim was to study the translational 
regulation of ILEI. 
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2 MATERIALS AND METHODS 
 
 
 
2.1 DNA techniques  
 
2.1.1 Design of oligonucleotides 
Oligonucleotides were used for PCR amplification and DNA sequencing. For site specific 
hybridisation, oligonucleotides must have 16 to 18 base pairs. For stringent annealing there 
should be Cs or Gs at the end of every sequence. Primers should also not have secondary 
structures meaning no complement sequences in itself. Also when primes were used together in 
the same experiment they should not be complementary to each other to avoid 
heterodimerisation. A melting temperature between 50°C and 60°C is desirable. The primers 
were dissolved in H2O to a concentration of 100µM. Storage is at -20°C. 
 
2.1.2 PCR (Polymerase Chain Reaction)  
Standard reaction of 50µl: 
5µl  PCR buffer (10x) 
3µl  MgCl2 (25mM) 
0,2µl  Taq Polymerase (5U/µl)  
2µl DMSO 
1µl  primer mix (5mM each) 
1µl  DNA 
Up to 50µl with ddH2O 
 
Standard program for the PCR was started with an initial denaturation step at 94°C for 5´. 
Then the following 35 cycles consisted a short denaturation step at 94°C for 30´´, an annealing 
step with a primer dependent temperature of 30´´, an elongation step at 72°C with 
approximately 1´for 1kb. A final elongation step for 5´at 72°C was applied for extending some 
unfinished elongation products and the reaction was hold on 4°C. 10x Orange G was to the PCR 
product added an loaded directly onto an agarose gel. 
 
Primers for UTR cloning: 
ILEI 5´ UTR forward  
ACGTAAGCTTCGCGATCGGCGCGCTCGGGAGG 
ILEI 5´ UTR reverse 
ACTGCCATGGATTTTTGCCTTCTCACTCTCTAGCAC 
ILEI 3´ UTR forward 
TATCTAGACGGGAAGGAGCGAGAGGC 
ILEI 3´ UTR reverse SHORT 
TTGGCGCGCCTTGTGTGAAACATTTTATTTCTGG 
ILEI 3´ UTR reverse LONG 
TTGGCGCGCCCAGTAAGTGAGCACTGTTCCAC 
 
Agarose gel electrophoresis 
Depending on the size of DNA fragments to be separated, the Agarose concentration varied 
between 1% and 2%. The Agarose was suspended in 1x TAE buffer and boiled in the microwave 
until it dissolved completely. After cooling down the solution a 0,5µl Ethidium Bromide (10mg/ml) 
was added. The mix was poured into a gel tray with a comb of choice. When the gel was hardened 
the comb was removed and the gel tray was put into a gel camber containing 1x TAE. The gel was 
run at 3V/cm2.  
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2.1.3 Determination of the concentration of nucleic acids 
The concentration of nucleic acids was determined by measuring the optical density of the 
sample that was diluted 1:200 in TE at 260nm in a spectrometer. As a blank 1x TE was used. 
Nucleic acid µg/ml = OD260 * 50 
 
2.1.4 Recovery of DNA from agarose gels  
The gel extraction was performed using GFX PCR DNA an Gel Band Purification Kit (Amersham 
Biosciences) according to the manufacturer’s instructions. Briefly, the gel band of interest was 
cut out of the Agarose gel and put in a pre-weighed tube. To 10mg of gel 10µl of capturing 
buffer was added, and incubated at 60°C for 15´ under shaking. The dissolved sample was 
transferred into a GFX column in a collection tube and incubated 1´at room temperature. 
Centrifuge at 13000rpm for 30´´. Flow-through was discarded. The Sample was washed with 
500µl wash buffer and centrifuged again. To elute the DNA from the column 40µl of ddH2O was 
added to the column, incubated for 1´ at room temperature and spined for 1´at full speed. The 
flow trough was collected.  
 
2.1.5 Purification of DNA from a PCR reaction 
The purification was performed using GFX PCR DNA an Gel Band Purification Kit (Amersham 
Biosciences) according to the manufacturer’s instructions. The PCR reaction was transferred 
onto a GFX column containing 500µl of capture buffer. Sample was mix by pipetting up an down. 
Centrifuge at 13000rpm for 30´´ and discard the flow-through. The Sample was washed with 
500µl wash buffer and centrifuged again. To elute the DNA from the column 40µl of ddH2O was 
added to the column, incubated for 1´ at room temperature and spined for 1´at full speed. The 
flow trough was collected.  
 
2.1.6 Restriction digestion of DNA 
The restriction digest reactions were performed with enzymes and buffers fron Roche and New 
England Biolabs. The reactions were always incubated at 37°C for 3 hours with a negative 
control. The enzymes were diluted at least 10 times in the reaction mix and 3U enzymes were 
calculated for 1µg of DNA.  
Standard reaction of 20µl: 
2µl  restriction buffer (10x) 
3U  restriction enzyme I per µg DNA 
3U  restriction enzyme II per µg DNA  
Xµg  DNA 
Up to 20µl with ddH2O 
 
2.1.7 Ligation of DNA 
All DNA ligations were carried out using T4 DNA ligase (Roche). They were carried out over 
night at 16°C always with an negative control in which was no Insert present to see if the vector 
has religated. The amount of vector to insert was near a 1 : 5 molar ratio.  
Standard reaction of 10µl: 
1µl   ligation buffer (10x) 
1µl  BSA (1mg/ml) 
0.5µl  T4 DNA ligase 
Xµmol   Vektor DNA 
5*Xmol  Insert DNA 
Up to 10µl with ddH2O 
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2.1.8 Heat-Shock transformation of DNA into competent bacteria 
For each transformation one vial (50µl) of heat shock competent cells of E. coli DH5α strain 
(stored at -80°C) were thawed on ice. 1µl of ligation mix was pipetted to the cells and mixed by 
gently tipping followed by a 30´ incubation on ice. Then the cells were put in 37°C warm water 
for 30´´ for the heat-shock, plated out on an LB-Amp plate and incubated over night at 37°C. At 
the same time, negative control in which only the cut vector without insert was used. 
 
2.1.9 Transformation of DNA into competent bacteria by electroporation 
For each transformation one vial (40µl) of electro competent E. coli cells JA226 strain (stored 
at -80°C) were thawed on ice. 1µl of the ligation mix was pipetted to the cells and mixed by 
gently tipping. At the same time, negative control in which only the cut vector without insert was 
used. Electroporation was performed at a voltage of 2,5kV. Cells were plated out on an LB-Agar 
plates containing the appropriate antibiotic and incubated over night at 37°C. For later storage 
parafilm was wrapped around the edges and the plate was put aside at 4°C.  
 
2.1.10 Small scale plasmid preparation (Mini-Prep) 
The plasmid preparations were made on the QIAGEN SPIN MINIPREP kit. After plates single 
bacterial colonies were grown out over night, they were picked and grown a another night in 5ml 
LB medium with the appropriate antibiotics. 1,5ml of this culture were spun down at 13000rpm 
for 3´. The bacterial pellet was resuspended with 250µl of buffer P1 and then mixed by 
inverting 4 times with 250µl buffer P2. Afterwards 350µl buffer N3 were added and mixed by 
inverting again. The reaction mix was centrifuged 10´ at 13000rpm and supernatant was applied 
onto the QIAprep spin columns by pipetting. After the vacuum drawn the solution through the 
columns, column was washed with 500µl of buffer PB and 750µl buffer PE. Transferred the 
columns to a microfuge tube and centrifuged 1´ full speed to remove all wash buffers. To elute 
the DNA the columns were placed in a clean tube and eluted with 40µl of ddH2O after incubating 
for 1´ at room temperature by spinning for 1´ at 13000 rpm.  
 
2.1.11 Large scale plasmid preparation (Maxi-Prep) 
The plasmid preparations were made with the QIAGEN SPIN MAXIPREP kit. The bacterial cells 
were harvested after growth for one night in 200ml LB medium with the appropriate antibiotics 
by centrifuging at 3500 rpm for 8´. The bacterial pellet was resuspended with 10ml of buffer P1 
and then mixed by inverting 4 times with 10ml buffer P2 and incubate at room temperature for 
5´. Afterwards 10ml buffer N3 was added and mixed by inverting again, incubated for 20´ on 
ice. The reaction mix was spinned for 15´at 3500rpm. A QIAGEN-tip 500 column was 
equilibrated with 10ml of QTB buffer and the supernatant was applied. After the supernatant 
was flown rough the column was washed wit 60ml of buffer QC. DNA was precipitated by adding 
10,5ml isopropanol at room temperature and centrifuged at 7000rpm for 30´at 4°C. The 
supernatant was discarded and the pellet washed wit 5ml 70% ethanol for another 10´at 4°C and 
7000rpm. The pellet was air-dried until it turned white but not longer otherwise one would not 
get it dissolved again. The pellet was dissolved in an appropriate amount of ddH2O (100µl – 500µl 
depending on the dimension of the pellet). 
 
2.1.12 Bac clone DNA isolation 
The Bac-plasmid preparations were made with the QIAGEN SPIN MAXIPREP kit. The bacterial 
cells were harvest after one night in 1000ml LB medium with the appropriate antibiotics by 
centrifuging at 6000 rpm for 10´. The bacterial pellet was resuspended with 45ml of buffer P1. 
The cells were divided up to 15ml per falcon (50ml) tube and 15ml buffer P2 was added to every 
tube followed by incubation at room temperature for 15´. Afterwards 15ml buffer N3 was 
added, mixed by inverting and incubated for 20´ on ice. The reaction mix was centrifuge 30´ at 
3500 rpm. A QIAGEN-tip 500 column was equilibrated with 10ml of QTB buffer and the 
supernatant was applied. After the supernatant was flown rough the column was washed wit 60ml 
MATERIALS AND METHODS _______________________________________________________________________________________________________________ 
________________________________________________________________________ 
37 
of buffer QC. DNA was precipitated by adding 10,5ml isopropanol at room temperature and 
centrifuged at 7000rpm for 30´at 4°C. The supernatant was discarded and the pellet washed 
wit 5ml 70% ethanol for another 10´at 4°C and 7000rpm. The pellet was air-dried until it turned 
white but not longer otherwise one would not get it dissolved again. The pellet was dissolved in an 
appropriate amount of ddH2O (100µl – 500µl depending on the dimension of the pellet). 
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2.2 Cloning strategies 
 
2.2.1 The inducible Tet-On system 
In general, vector and insert were digested with the same two enzymes, separated on agarose 
gel, gel extracted and ligated.  
 
pcDNA™4/TO was cut with BamH I and Xho I to insert the DNA fragment containing the coding 
sequence (CDS) for the Tet-On-ILEI construct and the FFL CDS for the pcDNA4/TO-FFL 
reporter construct (FIGURE 18).  
 
  
FIGURE 18 │  pcDNA™4/TO and pcDNA6/TR® vectors from Invitrogen.  
 
 
2.2.2 The UTR constructs 
 
The UTR constructs were cloned after amplifying the insert via PCR . The primer sequence and 
the procedure is noted under 2.1.2. After the PCR the fragments were purified (2.1.6) and 
digested (2.1.7) with the same enzymes as the vectors in which they were inserted.  
 
The pGL3-Control-MCS vector is a derivative of the pGL3-Control vector (FIGURE 19) were after 
the Xba I site a small multi cloning site (MSC) was inserted with restriction sites EcoR V and 
others (kindly provided from G. Obernosterer). 
 
 
FIGURE 19 │  pGL3-Control vector from Promega.  
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To generate the ILEI 5´-UTR construct the pGL3-Control-MCS vector was digested with Nco I 
and Hind III. 
The vectors ILEI 3´-UTR short and long were generated by digesting the pGL3-Control-MCS 
vector with Xba I and EcoR V.  
For the ILEI 5´and 3´-UTR short and long vector both digests mentioned above were carried 
out.  
 
The pGL3-Enhancer vector lacking the SV40 promotor served as negative control (FIGURE 20). 
 
 
FIGURE 20 │  pGL3-Enhancer vector from Promega.  
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2.3 RNA techniques 
 
2.3.1 Isolation of RNA  
 
2.3.1.1 TRIZOL Reagent Invitrogen 
Tissue samples (50 to 100mg) were homogenized in 1ml of TRIZOL reagent with a Polytron 
homogenizer (Kinematica). Cultured cells were trypsinised and washed with PBS before 1ml of 
TRIZOL agent was added. Homogenized samples were incubate for 5´ at room temperature to 
permit complete dissociation of nucleoprotein complexes. 200µl of chloroform was added and the 
tubes were shaken vigorously by hand for 15´´ and incubated for 3´ at room temperature. The 
samples were centrifuged at 13000rpm at 4°C for 15´. Upper aqueous phase was transfered into 
a fresh tube and precipitate the RNA by adding 500µl 2-propanol. By Incubating at 4°C for 10´ 
and followed by centrifugation at 13000rpm at 4°C. Supernatant was removed and the RNA 
pellet was washed with 1000µl 70% ethanol. The pellet was air-dried until it turned white and 
dissolved in 15µl of ddH2O. 
 
2.3.1.2 Quiagen RNeasy® Mini Kit 
Fresh RLT buffer was prepared by adding 10µl β-meraptoethalnol to 1ml RLT solution. Cells from 
culture dishes were trypsinised and washed. 350µl RLT buffer was added to disrupt the cell 
membranes and vortexed 1´. 350µl of 70% ethanol was added and mixed well by pipetting. The 
sample was transfered into a RNeasy spin column and vacuum was applied until transfer was 
complete. The column was washed with 700µl RW1 buffer. 10µl DNase I stock solution were 
added to 70µl RDD buffer and mixed by inverting. This mix was pipetted on the column and 
incubated 15´ at room temperature to digest the DNA completely. Then another 350µl of buffer 
RW1 was added and centrifuged at 13000rpm for 15´´. Flow-through was discarded. The column 
was washed twice with 500µl Buffer RPE. The column was removed from the vacuum manifold and 
placed in a tube, centrifuged at full speed for 1´ to get rid of all the buffer. The column was 
placed in a new tube and the RNA was eluted with 30µl of RNase-free water by centrifugation 
for 1´ at full speed.  
 
2.3.2 RNA clean up  
Fresh RLT buffer was prepared by adding 10µl β-meraptoethalnol to 1ml RLT solution. The 
sample volume was adjusted to 100µl with RNase-free water, 350µl RLT buffer was added and 
mixed well. 250µl pure ethanol was pipetted to the sample an it was placed in an RNeasy Mini spin 
column. The column was centrifuged for 15´´ at 13000rpm and the flow-through was discarded 
afterwards. The column was washed twice with 500µl RPE buffer. The column was removed from 
the tube and placed it in a new tube, centrifuged at full speed for 1´ to get rid of all the buffer. 
The column was placed in a new tube and the RNA was eluted with 40µl of RNase-free water by 
centrifugation for 1´ at full speed.  
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2.3.3 RNA nano chip 
The gel was prepared by putting 550µl of RNA 6000 Nano gel matrix (marked in red) into a spin 
filter and centrifugating at a bench centrifuge at full speed for 10´. RNA 6000 Nano dye 
concentrate (marked in blue) was vortexed (room temperature) and 1µl was added to 65µl of the 
filtered gel. The mix was vortex and spinned for 10´ at full speed. A RNA chip was put on the 
Chip Priming Station and 9µl gel-dye mix was pipetted in the well marked with G, the Chip Priming 
Station was closed and the plunger pressed until it was held by the chip. After waiting for 
exactly 30´´ the chip was released. 9µl of gel-dye mix were pipetted in the well marked G and 
5µl of RNA 6000 Nano Marker (marked in green) in all 12 sample wells and in the well marked 
with a ladder. In the well marked with a ladder also 1µl of RNA 6000 Nano ladder was pipetted. 
To each sample well 1µl of sample was added and the chip was vortexed  for 1´. The chip was run 
in the Agilent 2100 bioanalyzer within the next 5´ using the program: “eukaryote Total RNA 
Nano”.  
 
2.3.4 Isolation of polysome bound RNA on Sucrose-Gradient 
From the two basic sucrose solutions (15% and 40% (w/v)) two more solutions with 23.3% and 
31.6% (w/v) sucrose were prepared (by mixing the 15% solution with the 40% stock at ratios of 
2:1 and 1:2, respectively). 2.5 ml of complete 40% (w/v) sucrose mix were pipetted into RNase-
free polyallomer tubes for SW41 (Beckman) or equivalent swing-out rotor. These tubes are 
14mm in dameter and 89mm in length, and have a total capacity of 11 ml. In vertical position the 
tubes were quick-freezed in liquid nitrogen. 2.5 ml of 31.6% solution were pipetted on to the still 
frozen 40% layer, quick-frozen again and the same procedure repeated with the 23.3% and 15% 
solutions. Gradients were stored at -70°C until use. In the evening before the actual experiment, 
the required number of frozen sucrose gradient tubes were put into the cold room to thaw 
slowly overnight. Through convection the concentration steps formed a smooth, linear gradient 
by the next morning. 
Cells were harvested by trypsinising and washing the cells (5*10^7 per gradient). in 1131µl of 
cold NP-40 lysis buffer supplemented with 14,4µl RNasin Plus (40U/µl), 18µl cyclohexamid 
(10mg/ml), 24µl DTT (1M) and 12µl PMSF the cells were lysed for 15´ on ice. The lysate was 
centrifuged at 3300rcf for 3´ at 4°C in a microcentrifuge tube to pellet the nuclei. the 
supernatant was transferred to a new microcentrifuge tube containing 30µl heparin (50mg/ml ), 
together it was centrifuged at full speed for 10´ at 4°C, in a microcentrifuge tube to pellet the 
mitochondria and membrane particles. 1ml of the supernatant was pipetted on the sucrose 
gradient, and was centrifuged at 38000rpm, for 120´ at 4°C in an ultracentrifuge using an 
SW41Ti rotor. The acceleration was set to 5 (medium) and brake were switched off. The 
gradient was harvested in about 20 fractions of 550µl each into tubes containing 30µl of 20% 
(w/v) SDS, 12µl EDTA (0,5M) and 10µl proteinaseK (10mg/ml). This mixture was incubated for 30 
min at 37°C. Each fraction was extracted with 300µl Tris buffered phenol and 300µl chloroform 
: isoamylakohol 24:1. Phases were separated by centrifugation for 5´ in a microcentrifuge at 
13000rpm. 600µl of upper aqueous phase were recovered. 1ml of ethanol was added to 
precipitate the RNA at -80°C for 60´. Samples were centrifuged 30´ at full speed, supernatant 
was removed carefully, the pellet rinsed once with 500µl 70% ethanol; spinned for another 10´ 
at full speed and air dried. The pellet was dissolved in 15µl of RNAase-free water and stored at 
-70°C until use. 
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2.3.5 Northern blot 
Gel trays (14,5cm x 21cm) and combs were made RNase-free by incubating in 100mM NaOH for 
30´ followed by washing with RNase-free H2O. An appropriate amount of agarose was weighed 
for a 1,2% gel in 1x MOPS buffer. It was taken into account that formaldehyde (5,1ml/100ml) 
was added after boiling the agarose. By boiling, the agarose was dissolved and than cooled down 
to 50°C while stirring. In a fume hood, 5,1 ml of 37% (v/v) formaldehyde per 100ml of agarose 
solution and ethidium bromide (1,0mg/l) were added. After careful stirring the gel was poured 
immediately. The gel hardened for at least 45´. To 14µl of RNA solution 32,7µl denaturation 
buffer was added and incubated at 56°C for 15´, then 4,7µl of sample buffer was pipetted to 
the samples. The hardened gel was put into the electrophoresis chamber and filled up with 1x 
MOPS running buffer to cover the gel. The samples were loaded and run at 110V until the 
bromophenol blue was migrated about 2/3 of the gel length (about 4 hours). After the run was 
complete, a photograph of the gel under UV irradiation (302nm) was taken.  
Nylon membrane were cut to the same size as the gel. Thick Whatman papers soaked with 
RNase-free Na3PO4 (50mM). The surface of the Whatman papers had to be larger than the gel. 
The level of blotting buffer had to remain below the top surface of the sponge. Two pieces of 
filter paper (Whatman 3MM), of the same size as the sponge were wetted in the buffer and 
placed on top of the sponge. On top of this the gel with slots facing downwards on the filter 
paper were placed and the spacers inserted (e.g., parafilm strips, at least 3cm wide) along each 
side of the gel. The equilibrated nylon membrane was put on top of the gel. It was made sure 
that no air bubbles were trapped between gel and membrane. One piece of wet Whatman paper 
and two additional pieces of dry paper (cut to the same size as the gel) were placed on top of 
the membrane. Over that a stack of absorbent paper towels (50-75mm high) or further 
Whatman papers cut to the same size as the gel were put on top of the papers. A glass plate and 
a weight (500-1000g) were set on top of the paper towel stack. The transfer from the gel to the 
nylon membrane happened over night. In the morning the towels and filter paper were removed 
without lifting the nylon membrane. Mark the position of the slots and orientation of the filters 
were before. The slots on the gel were marked on the membrane with a soft pencil and lifted 
away from the gel. The gel was baked in an 80°C oven for 1 hour to dry the membrane 
completely. For a covalent fix of RNA to the membrane a UV cross-linker (such as Stratalinker 
(Stratagene) was used. 
 
2.3.6 Northern blot probe labelling 
A PCR of the fragment according to 2.1.2 was made and purified according to 2.1.5 then digested 
with the proper enzymes according to chapter 2.1.7. A Northern blot membrane was pre 
hybridisatied at 65°C for 1 – 2 hours in 20ml of church buffer. In a tube were 1 – 5µg of the 
DNA probe and up to 25µl ddH2O mixed with 10µl random primers. This mix was heated for 5´at 
99°C and spinned down briefly. 10µl dCTP buffer (10x) and 5µl P32-dCTP and 1µl Exo(-)Klenow 
(5U/µl) were added and incubated for 30´ to 60´ at 37°C. 2µl stop mix were pipetted to the 
reaction as well as 3µl yeast tRNA (10ng/µl) plus 25µl of a NH4Ac solution (7,5M).The sample was 
mixed and left 5´ at room temperature, then spinned down at 13000rpm for 5´ and the 
supernatant was discarded. The probe was washed with 70% ethanol and dissolved in 100µl  
1x TE. The radioactivity of the probe was checked with a GM-counter. For hybridization the 
radioactive probe was denatured at 95°C for 5´ and put right afterwards on ice. A change the 
church buffer (4ml) was made and the probe was pipetted directly into the fresh buffer in the 
tube with the membrane. Over night at 65°C the probe was hybrisided. In the morning the 
membrane was washed 3 times in wash buffer at room temperature for 5´ and once at 65°C for 
30´. The membrane was wrapped in a thin foil and exposed to auto radiographic films (Kodak Bio 
MAX X AR Film) at -80°C for minimum 2 days. If the membrane was needed for being probed a 
second time it was striped with stripping buffer for 30´ at 80°C. After stripping there was no 
need for pre-hybridization.  
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2.3.7 Reverse transcription of RNA into cDNA 
Standard reaction of 20µl: 
2µl  PCR buffer II (10x) 
4µl  MgCl2 (25mM) 
2µl dGTP (10mM) 
2µl dATP (10mM) 
2µl dCTP (10mM) 
2µl dTTP (10mM) 
1µl  RNase inhibitor 
1µl MuLV reverse transcriptase (50U/µl) 
1µl  random hexameres (50mM) 
1 - 5µg  RNA 
Up to 20µl with RNase-free water H2O 
The negative control was the standard reaction without reverse trankriptase.  
The standard programme for making cDNA was 10´ at room temperature than 60´ at 42°C 
followed by 10´ at 94°C. To the reaction mix 30µl of ddH2O were added  
 
β−Actin PCR 
Standard reaction of 50µl: 
5µl  PCR buffer (10x) 
3µl  MgCl2 (25mM) 
1 µl dNTPs mix (10mM each) 
0,2µl  Taq Polymerase (5U/µl)  
1µl  β-Actin primer mix (10mM each) 
1µl  DNA 
38,8µl ddH2O 
 
Standard program for the β-Actin PCR was started with an initial denaturation step at 94°C for 
5´.Then the following 25 cycles consisted a short denaturation step at 94°C for 30´´, an 
annealing step at 55°C for 30´´ an elongation step at 72°C for 45´. There was a final elongation 
step for 5´at 72°C was there for extending some unfinished constructs then the reaction was 
hold on 4°C. To the PCR product 10x OrangeG was added an loaded directly onto an agarose gel. 
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2.4 Protein chemistry 
 
2.4.1 Determination of protein concentration (Bradford assay) 
From a BSA stock solution with 1mg/ml a standard concentration row was prepared 2,5 - 
15µg/ml. The BioRad Bradford solution was diluted 1:5 with ddH2O. In a plastic cuvette 1ml of 
the diluted Bradford reagent was mixed with 1µl of a protein sample by covering the cuvette 
with a peace of parafilm and vortexing it briefly. After an incubation time of 5´the extinction at 
595nm was measured in a spectrophotometer.  
 
2.4.2 Cell lysis for SDS-PAGE 
A total protein preparation from eukaryotic cells growing in 6 well plates was made. The 
supernatant from the cells was collected and stored for later experiments. The cells were 
washed once with 1x PBS and trypsinised in 10x Trypsine. When they detached from the plate 
they were taken up in fresh FCS containing medium. At 2400rpm they were centrifuged for 3´ 
and the medium was discarded. The cells were washed again with 1x PBS and then lysed with 60µl 
lysis buffer. The lysing cells were incubated for at least 30´ on ice before centrifuging them at 
4°C for 30´ at 13000rpm. The supernatant was collected in a fresh tube and the protein 
concentration was measured with the Bradford method (2.4.1.).  
 
2.4.3 Supernatant preparation for SDS-PAGE 
From cells which were collected to be lysed for SDS-PAGE and Western blots the supernatant 
was taken and also loaded on a gel. For Ultra-filtration of a protein solution in Ultracel YM-10 
filters with a nominal weight limit of 10.000Da were used. The supernatant was collected in a 
tube and spined for 5´ at full speed on 4°C to sediment all celldebrie that would clog the filter 
columns. 500µl of the supernatant were placed in a MICROCON centrifugal filter device and 
centrifuged at 4°C for 30´ at 12300rpm. The tube with the filtrate was emptied and the column 
was put back in the tube. Another 500µl were put into the column and spinned again at 4°C and 
12300rpm for 15´. To get the concentrate the column was flipped up side down in a fresh tube 
and centrifuged for 1´ at room temperature, full speed. The volume of the supernatant 
concentrate was measured with a pipette.  
 
2.4.4 SDS-PAGE 
Protein samples were loaded on 10% PAGE gels with 1,0mm or 1,5mm thickness. PAGE running 
buffer was used and the gel ran at 200V and 40mA for about 2 hours.  
 
2.4.5 Western blot analysis (semi dry) 
For semi-dry Western blotting two filter papers Watman 3MM were soaked in blotting buffer, 
the PVDF membrane was soaked briefly in methanol and then in blotting buffer. The gel was 
moistened in the blotting buffer too and then the blotting sandwich was assembled.  
Filter paper – membrane – gel – filter paper. The transfer from gel to the membrane was 
performed in a Pharmacia Biotech Multiphor II unit at 20V and 56mA. For a mini gel (5,5cm x 
8,5cm) with 1mm 1 hour and a 1,5mm gel 1,5 hours at room temperature. After the transfer the 
gel was blocked 1 hour at room temperature or over night at 4°C with a blocking buffer. The 1st 
antibody was incubated 1 hour at room temperature or over night at 4°C in blocking buffer. The 
membrane was washed 3 times for 10´ in wash buffer and followed by 1 hour at room 
temperature or over night at 4°C in incubation with the 2nd antibody in blocking buffer. Finally 
the membrane was washed again 3 times for 10´ in washing buffer. For detection the membrane 
was moistened with ECL plus Western blotting Detection solution and under safe light conditions 
a high performance chemoluminescence film was put on it. After an incubation time that can 
range from 1´´ to 1´ the film was developed.  
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2.5 Cell culture 
 
2.5.1 Cultivation of adherent mammalian cells 
All cell lines were grown in the appropriate media in plastic culture dishes in an incubator at 5% 
CO2 level and 95% humidity at 37°C. The cells were split when they ere 95% confluent mostly 1:4 
every second day.  
Cell line  medium 
EpRas   4% FCS in EAGL 
EpC40   10% FCS in EAGL 
EpH4   10% FCS in EAGL 
XT   15% FCS in DMEM F12 
The EAGL medium was supplemented with an antibiotic and Hepes.  
Penicillin  100U/ml 
Streptomycin  0,1mg/ml 
Hepes pH= 7,3  0.02M 
 
2.5.2 Freezing of adherent cells 
Cells were trypsinised and pelleted (1200rpm for 5´) and resuspended in 1,5ml FCS containing 
10% DMSO. The cells were frozen to –80°C in cryogen micro tubes (Nalgene) and after at least 
49 hours transferred into liquid nitrogen at -192°C. Normally one 10cm dish was frozen in one 
cryo tube.  
 
2.5.3 Thawing of adherent cells 
Cells were thawed quickly at 37°C in a water bath and then transferred in fresh media. The cells 
were centrifuged at 1200rpm for 5´ the medium was discarded. Then the cells were 
resuspended into new media and plated out on the appropriate dish.  
 
2.5.4 Liposome based transfection of adherent mammalian cells 
The day before transfection of the cells were plated out with 400.000 cells per 6 well. For the 
transfection two tubes (A and B) were prepared. In tube A were 2µg of the DNA for the 
transfection mixed with 125µl Optimem. In tube B were 10µl Lipofectamin™ 2000 mixed with 
240µl Optimem. Both tubes were incubated for 5´ at room temperature. Then tube A was 
pipetted into tube B, they were mixed thoroughly and incubated for 20´ at room temperature. 
750µl Optimem were added to tube B and mixed. The mixture was put to the cells on a 6 well 
plate and the cells were incubated for 5 hours. After that the media was changed to the suitable 
one for the cells. At the next day cells could be harvested to be used either for SDS-PAGE gels, 
Luciferase assays or for sub cloning.  
 
2.5.5 Subcloning of cell lines via single cell sort 
Transfected cells were selected with an suited antibiotic for as long as the control dish without 
the protective construct needed to die. After that the cells were trypsinised an resuspended 
into media with Ciproxin (2mg/ml) and EDTA (20µg/ml) for sorting in a FACS machine into 96 
well plates, one cell per well or two cells per well. The media was changed one week after the 
sort and the well were checked under the light microscope for grown colonies. When the colonies 
were 80% confluent the cells were successively expanded. To guarantee, that the cells keep the 
transfected construct the cells media was supplemented from time to time with antibiotics.  
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2.5.6 Establishing stable transfected cell lines 
pcDNA6/TR® TetR cells:  
EpH4-TetR, EpC40-TetR and EpRas-TetR cells were selected with Blasticidin (25µg/ml). As 
control there was always one plate of the corresponding parental cell lines selected as well. The 
selection was ended when the parental cells were dead.  
 
pcDNA4/TO®-ILEI Tet-On-ILEI cells: 
EpH4-Tet-On-ILEI, EpC40-Tet-On-ILEI and EpRas-Tet-On-ILEI cells were selected with 
Zeocin (2mg/ml) and Blasticidin (25µg/ml) at the same time. As control there were always one 
plate of the corresponding parental cell lines selected as well. The selection was ended when the 
parental cells were dead.  
 
2.5.7 Dox induction (Tet-ON system) 
To induct the Tet-ON systems the cells were plated out and when they adhered they were 
treated with Doxicycline hyclate (5µg/ml) for 24 hours. After that, the cells were harvested 
and the total protein was checked on a SDS-PAGE gel or used for luciferase assays.  
 
2.5.8 TGFβ induction  
To induced the cells systems the cells were plated out and when they adhere they were treated 
with TGFβ (5ng/ml) for 24 hours. After that cells were harvested and the total protein was 
checked on a SDS-PAGE gel or used for luciferase assays.  
 
2.5.9 Renilla FFL reporter assays 
Transfected cells (2.5.4) were grown on 96well plates and induced with Dox as described in 
2.4.7. The firefly luciferase activity (FFL) was measured by adding a volume of Dual-Glo 
Luciferase Reagent equal to the culture medium to each well and mixed. For a 96 well plate it 
was typically 100µl. The plate was incubated at room temperature at least for 10´ before 
measuring the firefly luminescence. To measure the Renilla luciferase activity a volume of Dual-
Glo Stop & Glo Reagent equal to the culture medium was added to each well and mixed. 10´ the 
mix was incubated and the Renilla luminescence was measured. The ratio of luminescence from 
Renilla to FFL was calculated. This ratio was normalised to the ratio of a control well into which 
no DNA was transfected. The calculations were performed in Excel.  
 
2.5.10 In vitro cell assays in collagen gels 
To allow three-dimensional growth of the cells in vitro they were seeded in collagen gels. The 
day before pouring the gels the cells were splitted to 50% confluence. The collagen stock 
solution (concentration varies with batch) was diluted with the 10% FCS media to an end-
concentration of 1,6 mg/ml. Cells (in their appropriate media) and collagen were pre-cooled on ice 
and pipetted careful the cells into the collagen. To get a uniform mixture it was pipetted up and 
down to avoid bubbles. The mixture of cells and collagen was pipetted onto a planar working place 
100µl per well (24 well plate) forming a drop. The gel polymerised at room temperature in 10´ 
then the plate was placed in a humid chamber at 37°C for approximately 90´. The gels were fed 
afterwards and put back on 37°C. Next day, the feeding was repeated with fresh media. The 
next feeding with freshly prepared media was every other day until the cells formed structures. 
Depending on the cells 1000- 2000 cells per well were seeded.  
Serum free collagen gel medium:  DMEM-F12 
+ BPE   13µg/ml  Bovine pituitary extract 
+ DEX   1µmol/l   Dexamethasone 
+ IP   10nM   Isopropterinol 
+ TGFα  5ng/ml 
+ Insulin 0,04 I.E./ml 
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2.5.11 In vitro cell assays on filters 
For the filter experiments 50.000 cells were plated out per filter (Falcon 3090). Every other 
day Dox (5µg/ml) was added to the medium in cases of + Dox treatment. On every 2nd day the 
cells were trypsinised and from these cells 50.000 were plated out on fresh filters. Underneath 
a 6 well filter were 2,7ml of medium and above the filter 1,5ml. For long term exposure to Dox 
cells were grown on filters for more than 8 days.  
 
2.5.12 Proliferation curve 
On 6cm dishes 250.000 cells were plated out. From each clone triplicates were made with and 
without Dox treatment. Every other day Dox (5µg/ml) was added to the medium in cases of +Dox 
treatment. On every 2nd day the cells were trypsinised and counted with CASY®1 (Scharfe 
System) cell counter. The range of living cells was in this case 10 - 30µm in diameter. After the 
cell counting 250.000 cells were plated out again. This Procedure was done over 8 days.  
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2.6 Mouse work 
 
2.6.1 Mammary gland fat pad injection of tumor cells 
The cells for injection were trypsinised counted and washed in PBS. The cells were set up so 
that 100.000 cells were in 30µl PBS. The mice were narcotised with a mixture of Ketamine 
(5mg/ml) and Xylazine (0,8mg/ml) 0,2ml per 10g body mass of the mouse. The narcotic was 
injected intra peritoneal. In every fat pat 30µl of cell suspension were injected. Tumor growth 
was measured with the calliper ruler. To calculate the Volume of the tumor this equation was 
used: (width2 x length)/2.  
 
2.6.2 Tail vain injection of tumor cells  
The cells for injection were trypsinised, counted and washed in PBS. The cells were set up so 
that 100.000 cells were in 100µl PBS. The mice were secured in a special apparatus where they 
could not move. The tail was put under a infra red light so that the tail vain expanded under the 
warmth. In every tail vain 100µl of cells suspension were injected.  
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2.7 Histology 
 
2.7.1 Preparation of frozen tissue samples 
The exgrafted tumors from mice where washed in 1x PBS to clear them from blood. In a plastic 
cubicle a layer of Tissue-Tec was given and put onto dry ice until the underside froze a bit, then 
the tumor was embedded in Tissue-Tec. After the whole cube was frozen solid the embedded 
tissue was stored at -80°C. 
 
2.7.2 Preparation of PFA-fixed and paraffin embedded tissue sections 
The exgrafted tissue was washed once in PBS so that all blood was removed and then fixed in a 
4% PFA solution over night at 4°C. The tissue was dehydrated in Tissu-Tek VIP machine. 
Dehydrations protocol: 
Solution  how long   temperature 
Ethanol 70%  2 hours  37°C 
Ethanol 80%  1 hour   40°C 
Ethanol 96%  1 hour   40°C 
Ethanol 100%  1 hour   40°C 
Ethanol 100%  1 hour   40°C 
Xylol   1 hour   40°C 
Xylol   1 hour   40°C 
Paraffin   1 hour   60°C 
After that the exgrafts were put in a cage with hot paraffin and cooled until they were solid. 
The paraffin blocks were stored at room temperature.  
4µm sections of -10°C pre-cooled paraffin-embedded tissue samples were obtained by cutting 
with a microtome (HM 355s) and applied on super frost+ glass slides in a warm water bath. For 
deparafinisation the slides were baked in an oven at 65°C for 1 hour.  
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2.8 Immunocyto- and Immunohistochemistry 
 
2.8.1 Staining of Collagen gels 
The gels were fixed in -20°C cold acetone : methanol 1:1 mixture for 10´ at -20°C. To rehydrate 
them they were washed with a series of ethanol water mixtures (100%, 70%, 50%, and 25% 
ethanol), once with PBS then three times with PBST. To block the gels a solution of PBST with 
0,2% gelatine and 1:1000 bovine IgG was piped on them. The 1st antibody was diluted in blocking 
solution and put on the gels for 1 hour. The gels were washed three times rapidly with PBST and 
three more times slowly in PBST. The 2nd antibody was also applied in blocking solution and 
incubated for 1 hour. To obtain a background as low as possible the gels were washed three 
times rapidly with PBST and three times slowly with PBST. After that the gels were put on glass 
slides and mounted with Prolong Gold (Promega) in which DAPI was already present. The slides 
were kept at room temperature for one night to dry and were sealed with nail polish on the 
edges the next day. After that the slides were stored at 4°C.  
 
2.8.2 Staining of PFA-fixed paraffin-embedded tissue sections 
 
2.8.2.1 Hematoxylin and Eosin staining 
Staining protocol in Shandon Thermo machine at room temperature: 
Solution  how long 
2x Xylol  10´ 
2x Ethanol 100% 2´ 
Ethanol 90%  30´´ 
Ethanol 80%  30´´ 
Ethanol 70%  30´´ 
Ethanol 30%  30´´ 
H2O   1´ 
Hematoxylin 0,4% 5´ 
H2O   2´ 
HCl 4,4mM  6´´ 
H2O   2´ 
H2O   1´ 
H2O   5´ 
Ethanol 30%  30´´ 
Ethanol 70%  30´´ 
Ethanol 80%  30´´ 
Eosin 0,5%  20´´ 
Ethanol 90%  30´´ 
Ethanol 100%  30´´ 
2x Xylol  2´ 
 
2.8.2.2 Cleaved caspase 3 staining 
This stainings were taken in Ventana Discovery with the ChromoMap™ DAB kit in combination 
with UltraMap™ kit. 
 
2.8.2.3 Ki67 staining 
This stainings were taken with the DABMap™ DAB kit in in Ventana Discovery machine. From 
every tumor three frames were photographed at different sites. For the evaluation of the 
stainings the number of blue and brown stained nuclei was counted manually in every frame. The 
total number of nuclei served as 100% for calculations.  
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2.8.2.4 ILEI staining 
Memo kindly stained this glass slides for me.  
Solution   how long  temparature 
Deparafination 
3x Xylene   7´   RT 
Ethanol 100%   1´   RT 
Ethanol 100%   1´   RT 
Ethanol 50%   1´   RT 
Ethanol 50%   1´   RT 
3x H2O   1´   RT 
Retrieval buffer ∞  20´   99°C 
The slides were removed from the retrieval buffer and air-dried at RT. Tissues were encircled 
with a PAP pen.  
The following drop reactions (*) were obtained in a wet chamber. 
1x PBS    8´ 
Goat serum 29%  15´ (*) 
Rabbit anti ILEI antibody # 60´ (*) 
1x PBS    10´´ 
1x PBS    2´ 
1x PBS    2´ 
Blocking endogenous peroxidise 
H2O2 / 1x PBS 0,3%  20´ 
Goat anti rabbit antibody 30´´ (*) 
1x PBS    10´´ 
1x PBS    2´ 
1x PBS    2´ 
Streptavidine-biotine §  30´ (*) 
1x PBS    10´´ 
1x PBS    2´ 
1x PBS    2´ 
Coulour development in AEC∆ 6´ to 8´  
H2O    1´  
Hematoxylin 1g/l  2´ to 3´ 
H2O   every 30´´ over 8´ 
The slides were dried at RT for about 15´,mounted with Aquatex solution and covered with 
slides.  
 
# Rabbit anti ILEI polyclonal antibody. Dillution 1:300, pre-incubated with a pool of 8ng/ml of 
momologous peptides Fam3A and Fam3D to avoid cross reactions.  
∞ EDTA1mM/Tween20 0,05% pH=8 
§ Streptavidin-biotin complex. 1ml 1x PBS was mixed with 10µl solution A, and 10µl solution B. The 
mixture was incubated at RT for 30´ after that 1ml 1x PBS and 20µl horse sera was added.  
∆ AEC Solution 3,3-amino-9-ethyl carbazole in 100ml N,N-dimethylformamid. For working 
solution 7ml stock were added to 200ml sodium-acetate buffer (20mM, pH=4,9) and filtered. 
Finally 22µl H2O2 were added. 
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2.9 Microscopy 
 
2.9.1 Light and fluorescence microscopy 
For light microscopy pictures of histological stainings the Axioplant 2 from Zeiss was used with 
Image Acsess software. The light microscopy cell pictures were taken with a Leitz Laborvert FS 
microscope with Scion Image software. For the pictures of the collagen gels the Zeiss Axiovision 
microscope with metamorph software was used.  
 
2.9.2 Confocal microscopy 
All pictures of stained collagen gels are single Z-stack photos made with a Zeiss LSM510 
confocal microscope with LSM510 software. 
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3 RESULTS 
 
 
 
3.1 Generating the TetR clones 
 
To learn something about the relevance of ILEI levels in tumor progression and growth we 
decided to generate inducible ILEI over-expressing clones in the EpH4 cell system.  
 
For the transfection of the cells with the two constructs of the T-Rex inducible expression 
system a stepwise approach was used (FIGURE 21). Clones were selected and characterised for an 
unchanged phenotype after each step. 
 
 
 
FIGURE 21 │  Cloning strategy and stepwise approach for transfection.  
 
For the generation of TetR clones EpH4, EpC40 and EpRas parental cells were transfected with 
the pcDNA6/TR® vector. The transfected TetR cells were selected with Blasticidin (25µg/ml) 
(for minimum 5 days) followed by isolation of single cell clones. TetR-clones with epithelial 
phenotype were elected for further studies were following transiently transfected with the 
pcDNA4/TO-FFL reporter and the pRL-TK2-Renilla control vector. To test the inducibility of 
the TetR-clones, they were cultured in the presence and absence of Doxicycline (Dox) (5µg/ml) 
for 24 hours. A combined FFL Renilla dual luciferase reporter assay pointed out the high 
expressing clones of each cell line (FIGURE 22).  
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FIGURE 22 │ Inducibility of the best TetR clones from each cell line. 
EpH4-TetR clone expresses 9,7 times more FFL upon Dox induction than the uninduced one. The 
induced EpC40-TetR clone expresses 3,5 times more of the reporter gene than the uninduced control. 
In case of the EpRas-TetR cells the induction with Dox increases the FFL expression by 6,2 fold. The 
error was calculated with standard deviation (SD). 
 
Some of the single cell clones were excluded from further studies based on slow growth rate or 
loss of epithelial morphology. From all the clones only a few had an induction capability of over 
two fold (TABLE 2). Statistically 50 to 100 clones had to be analysed in order to get a clone with 
reasonable inducibility.  
 
  EpH4-TetR EpC40-TetR EpRas-TetR 
  No. % No. % No. % 
              
Clones transferred from 96 to 24 well plates 557   506   166   
Clones grown on 24 well plates after expansion 463 83,1 470 92,9 143 86,1 
Clones tested in the luciferase reporter assay 170 30,5 235 50,0 92 55,4 
Clones with induction capacity < 1 fold 28 16,5 115 48,9 39 42,4 
Clones with induction capacity of 1 - 1,5 fold 88 51,8 112 47,7 49 53,3 
Cones with induction capacity of 1,5 - 2,0 fold  49 28,8 5 2,1 2 2,2 
Clones with induction capacity > 2,0 fold 5 2,9 3 1,3 2 2,2 
TABLE 2 │ Statistics of tested Tet-R clones.  
The number of clones transferred to 24 well plates is 100% to the next two rows. For the calculations 
of induction capacity the number of luciferase tested clones was taken as 100%. 
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3.1.1 In vitro characterisation of the TetR-clones 
It was necessary to characterise the TetR-clones with reference to the parental cell lines so 
that further experimental data with the over expressed gene of interest are comparable to the 
original cell lines. First, the morphology on plastic was determined (FIGURE 23). 
 
 
FIGURE 23 │ Epithelial morphology of the parental cell lines and the TetR clones on plastic culture dishes. 
A) parental cell lines B) TetR clones 
 
There were no differences in morphology between the parental cell lines and the TetR clones to 
observe when cells were grown on plastic culture dishes.  
 
The morphology of parental cell lines and TetR-clones was also tested in collagen gels upon TGFβ 
treatment (FIGURE 24). In all cases the parental cells and the TetR clones grow in their typical 
structures and reacted as expected to TGFβ treatment.  
 
EpH4 and EpH4-TetR cells form both hollow, organotypic structures and die upon TGFβ 
treatment (FIGURE 24 A and B).  
EpC40 and EpC40-TetR cells form hollow structures without TGFβ and undergo scattering when 
TGFβ is added. Scattering cells move out of the collective structures and are spindle shaped 
(FIGURE 24 C and D).  
EpRas and EpRas-TetR cells form hollow spheres of cells without TGFβ and undergo EMT upon 
TGFβ treatment which can be seen in the spiky, invasive outgrowths (FIGURE 24 E and F).  
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FIGURE 24 │ Comparison of the parental cell lines and the TetR clones in collagen gels upon TGFβ treatment.  
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The changes in marker expression upon TGFβ treatment was checked in collagen gels  
(FIGURE 25 to 27).  
 
 
 
 
FIGURE 25 │ Marker staining of EpH4 and EpH4-TetR cells in collagen gels upon TGFβ treatment.  
A) parental EpH4 cells in the top panel stained for E-cadherin (red), actin (green) and DNA (blue) 
and in the bottom panel stained for Vimentin (red), actin (green) and DNA (blue). 
B) EpH4-TetR cells, stained the same way.  
 
EpH4 and EpH4-TetR cells show both strong E-cadherin staining but no vimentin staining  
(FIGURE 25).  
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FIGURE 26 │ Marker staining of EpC40 and EpC40-TetR cells in collagen gels upon TGFβ treatment.  
A) parental EpC40 cells in the top panel stained for E-cadherin (red), actin (green) and DNA (blue) 
and in the bottom panel stained for Vimentin (red), actin (green) and DNA (blue). 
B) EpHC40-TetR cells, stained the same way.  
 
EpC40 and EpC40-TetR cells show both strong cortical E-cadherin expression, which is down 
regulated when TGFβ is added. Vimentin staining is not present in EpC40 or EpC40-TetR cells 
neither with nor without TGFβ treatment (FIGURE 26).  
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FIGURE 27 │ Marker staining of EpRas and EpRas-TetR cells in collagen gels upon TGFβ treatment.  
A) parental EpRas cells in the top panel stained for E-cadherin (red), actin (green) and DNA (blue) 
and in the bottom panel stained for Vimentin (red), actin (green) and DNA (blue). 
B) EpRas-TetR cells, stained the same way.  
 
EpRas and EpRas-TetR cells express E-cadherin when no TGFβ is present and down regulate it 
when TGFβ is added. Vimentin is not present without TGFβ but when cells are treated with TGFβ 
it is expressed (FIGURE 27). 
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3.1.2 In vivo characterisation  
After the in vitro characterisation mouse experiments were performed to compare the parental 
cell lines with the generated TetR clones in vivo. Tumor growth was tested by injecting 100.000 
cells to the mammary gland fat pads of nude mice. The growth was measured for several weeks 
(FIGURE 28).  
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FIGURE 28 │ Tumor growth of all parental cell lines and TetR clones in nude mice.  
The error bars were calculated with standard deviation (SD). 
 
The graph in FIGURE 28 shows that both parental EpRas cells and EpRas-TetR cells formed 
tumors, in contrast to EpC40 and EpC40-TetR as well as EpH4 and EpH4-TetR cells. In 
comparison to the EpRas parental cells the EpRas-TetR cells grow slower (FIGURE 28). After a 
long period EpC40 and EpC40-TetR cells formed nodules as well, indicating a very slow tumor 
growth of EpC40 and EpC40-TetR cells. This is why in the following experiments a 10 fold higher 
number ob EpC40-TetR cells was used (FIGURE 29).  
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FIGURE 29 │ Tumor growth of EpC40 and EpC40-TetR cells in nude mice.  
The error bars were calculated with standard deviation (SD). 
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The metastatic capabilities of EpRas, EpC40 and both TetR clones were investigated by tail vain 
injection. 100.000 cells per mouse were injected intravenously to see if the lung would be 
colonised by these cells (FIGURE 30). The survival of the mice was monitored after tail vain 
injection.  
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FIGURE 30 │ Survival rate of nude mice after tail vain injection of EpRas, EpRas-TetR, EpC40 and EpC40-
TerR cells.  
 
The blot shows that parental EpRas cells developed lung metastases faster than the 
corresponding TetR cells. This agrees with the observation that they showed slower tumor 
growth. Both, EpC40 and EpC40-TetR cells failed to form lung metastases.  
 
Metastasis formation was confirmed by the analysis of the lungs from the dead mice. The lungs 
of mice with injected parental and TetR cells were dissected and compared (FIGURE 31). 
 
 
FIGURE 31 │ Lung colonisation of parental and TetR cells in nude.  
The dissected lungs mirrored the results of the survival statistics. No metastases in EpC40 and 
EpC40-TetR injected mice and huge metastases in EpRas and EpRas-TetR mice were observed.  
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3.2 Tet-On-ILEI overexpressing clones  
 
ILEI was cloned into the multiple cloning site of the pcDNA4/TO® expression vector. For the 
generation of Tet-On-ILEI clones, EpH4-TetR, EpC40-TetR and EpRas-TetR cells were 
transfected with the pcDNA4/TO®-ILEI vector. The transfected Tet-On-ILEI cells were 
selected with Zeocin (2mg/ml) followed by isolation of single cell clones. Some of the single cell 
clones were excluded from further studies based on slow growth rate or loss of epithelial 
morphology (TABLE 3).  
 
  EpH4-Tet-On-ILEI EpC40-Tet-On-ILEI EpRas-Tet-On-ILEI 
  No. % No. % No. % 
              
Clones transferred from 96 to 24 well plates 53   61   49   
Clones grown on 24 well plates after expansion 39 73,6 47 77,0 29 59,2 
Cells with mesenchymal phenotype 7 17,9 21 44,7 1 3,4 
Expanded cells with epithelial phenotype 32 82,1 26 55,3 28 96,6 
TABLE 3 │ Statistics of tested Tet-On-ILEI clones 
 The number of clones transferred to 24 well plates is 100% to the next row. For the cells with 
epithelial and mesenchymal phenotype the expanded cells on 24 well plates were taken as 100%. 
 
 
3.2.1 In vitro characterisation of the Tet-On clones 
 
3.2.1.1 Western blot analysis for inducibility 
To test the inducibility of the Tet-On-ILEI-clones they were cultured in the presence or 
absence of Dox (5µg/ml) for 24 hours. Western blot analysis of concentrated supernatant (SN) 
and whole cell lysates (IC) was used for each cell line to identify clones with high ILEI 
inducibility (FIGURE 32 to 34).  
 
 
FIGURE 32 │  Western blot analysis for ILEI on culture supernatant (SN) and on whole cell lysate (IC) of  
EpH4-Tet-On-ILEI cells with or without Dox induction. 
 
The analysis on Western blot shows that the EpH4-Tet-On-ILEI clone #23 has slightly elevated 
ILEI levels in the supernatant and elevated intracellular ILEI levels when treated with Dox in 
comparison to no Dox treatment. In case of the EpH4-Tet-On-Empty control the ILEI levels 
were not enhanced with Dox addition.  
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FIGURE 33 │  Western blot analysis for ILEI on culture supernatant (SN) and on whole cell lysate (IC) of  
EpC40-Tet-On-ILEI cells upon Dox induction or without induction. 
 
EpC40-Tet-On-ILEI clone #20 had low levels of ILEI in general but when induced with Dox, the 
ILEI levels were higher, predominantly in the supernatant. The EpC40-Tet-On-ILEI clone #40 
showed generally high ILEI levels with or without induction but when induced with Dox, the 
supernatant- and intracellular ILRI levels were elevated.  
 
 
FIGURE 34 │  Western blot analysis for ILEI on culture supernatant (SN) and on whole cell lysate (IC) of  
EpRas-Tet-On-ILEI cells upon Dox induction or without induction. 
 
EpRas-Tet-On-ILEI clone #16 had a high basal ILEI level nevertheless showed nicely elevated 
ILEI levels upon expression with Dox both intracellularly and in the supernatant. The EpRas-Tet-
On-ILEI clone #17 had a lower ILEI expression without induction, than the clone #16 but a 
strikingly high inducibility.  
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3.2.1.2 Proliferation curves 
To see if the Dox induction and therefore the higher ILEI concentration in the cells and in the 
surrounding medium had an effect on growth rate. Proliferation studies were performed (FIGURE 
35 to 37).  
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FIGURE 35 │  Proliferation curve of different EpH4-Tet-On-ILEI clones with and without Dox induction.  
The error bars were calculated with standard deviation (SD). 
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FIGURE 36 │  Proliferation curve of different EpC40-Tet-On-ILEI clones with and without Dox induction.  
The error bars were calculated with standard deviation (SD). 
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FIGURE 37 │  Proliferation curve of different EpRas-Tet-On-ILEI clones with and without Dox induction.  
The error bars were calculated with standard deviation (SD). 
 
For all clones in all cell lines it is true that the uninduced cells grow a bit faster then the ones 
treated with Dox. However this difference was not significant. This indicates, that ILEI had no 
effect on cell proliferation.  
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3.2.1.3 Morphology of the Tet-On clones 
We tested if there were morphological changes on plastic when Dox was added for a longer 
period of time (minimum 8 days). On plastic, there were no differences visible in all tested cell 
lines.  
 
To see if morphological differences were developed when cells are grown on porous supports, 
EpC40-Tet-On-ILEI cells were treated prolonged with Dox. This way secreted ILEI has not only 
to the apical membrane but also to the basolateral membrane free access. As a representative 
example for all cell lines experimental data of EpC40-Tet-On-ILEI cells are shown (FIGURE 38).  
 
 
FIGURE 38 │ EpC40-Tet-On-ILEI clones grown on porous support.  
 
No morphology changes could be observed by long-term Dox treatment on porous support 
compared to untreated cells.  
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In collagen gels, the morphology of EpRas-Tet-On-ILEI and EpH4-Tet-On-ILEI was the same 
regardless if treated with Dox or not. The only cells showing a slight difference were EpC40-
Tet-On-ILEI #40 (FIGURE 39) 
 
 
 
FIGURE 39 │  Collagen gels of EpC40-Tet-On-ILEI empty with different TGFβ concentrations. 
First slide with no TGFβ treatment, second slide 5ng TGFβ treatment and third slide first a 5ng TGFβ 
treatment for 2 days and then a 4 to 5 days withdrawal. In the upper panel no Dox, lower panel 1ml/ml 
Dox over the whole period of the experiment.  
 
Normally, EpC40 cell form tubular, epithelial structures in collagen gels. This changes to a 
scattering phenotype upon TGFβ treatment in a reversible manner. Thus the TGFβ induced 
scattering, spindle shaped migrant cells reverted back to more rounder, compact structures if 
the factor is withdrawn. As expected, EpC40-Tet-On-Empty cells showed exactly this phenotype 
regardless the addition of Dox. It was the same in case of EpC40-Tet-On-ILEI #40 in the 
absence of Dox. Addition of Dox had also no effect on the epithelial structure formation and 
scattering phenotype of EpC40-Tet-On-ILEI cells. However, in the presence of Dox these cells 
showed a lack of epithelial reversion after TGFβ withdrawal, and kept their spiky morphology.  
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3.2.2 In vivo characterisation of the EpRas-Tet-On-ILEI and EpC40-Tet-On-ILEI clones 
After the in vitro characterisation mouse experiments were done to compare tumor formation 
and lung colonisation of EpC40-Tet-On-ILEI and EpRas-Tet-On-ILEI cell lines with and without 
Dox induction.  
 
The tumor growth of the different EpC40-Tet-On-ILEI clones was tested in the same way as in 
the case of EpRas-Tet-On-ILEI with the exception, that 1.000.000 cells per fat pad were 
injected (FIGURE 40). The greater number of cells is because the EpC40 cells grow slower in vivo 
than the EpRas cells (see chapter 3.1.4).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 40 │  Time course of tumor growth of EpC40-Tet-On-ILEI clones #20 and #40 with or without Dox.  
The error bars were calculated with standard error of means (SEM). 
 
The EpC40-Tet-On-ILEI clone #20 showed a slight increase in tumor growth when treated with 
Dox in contrast to the untreated one. The difference is not significant but a tendency is there. 
The EpC40-Tet-On-ILEI clone #40 shows no difference in tumor volume with or without Dox 
and has a faster tumor growth in general. These findings are reflected in the Western blots, 
where the two clones were induced. Clone #20 had a lower basal level of ILEI in comparison to 
clone #40.  
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When the EpC40-Tet-On-ILEI tumors #20 and #40 exceeded a certain dimension they were 
excised after scarification of the mice and weighed (FIGURE 41).  
 
 
FIGURE 41 │  Tumor mass of EpC40-Tet-On-ILEI clones #20 and #40 upon Dox induction.  
The error was calculated with standard error of means (SEM). 
 
The clone EpC40-Tet-On-ILEI #20 shows some differences upon Dox induction in contrary to 
the EpC40-Tet-On-ILEI clone #40, which showed no differences in growth upon Dox induction. 
This might be a result of the already higher ILEI levels in the clone #40.  
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Tumor growth in the EpRas-Tet-On-ILEI cell lines was tested by injecting 100.000 cells in to 
the mammary gland fat pads of nude mice. The Tumor diameter was measured over several 
weeks (FIGURE 42). To ensure Dox induction, the drinking water of mice was supplemented with 
5% sucrose either with or without 1mg/ml Dox and changed every second day.  
 
 
FIGURE 42 │ Tumor growth of EpRas-Tet-On-ILEI clones #16 and #17 upon Dox induction in nude mice.  
The error bars were calculated with standard error of means (SEM). 
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When the EpRas-Tet-On-ILEI tumors #16 and #17 exceeded a certain dimension they were 
explanted and weighed (FIGURE 43).  
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FIGURE 43 │ Tumor mass of EpRas-Tet-On-ILEI clones #16 and #17 upon Dox induction.  
The error bars were calculated with standard error of means (SEM). 
 
The EpRas-Tet-On-ILEI clone #16 showed no differences in growth upon Dox induction. This 
may be a result of the already high ILEI levels without induction. Significant differences 
between + and – Dox induction were seen in clone EpRas-Tet-On-ILEI #17. 
 
To analyse the metastatic capabilities of the two EpRas-Tet-On-ILEI clones 100.000 cells per 
mouse were injected into the tail vain. The lungs of the animals were dissected at the same time 
point to see the metastatic nodules (FIGURE 44).  
 
 
FIGURE 44 │ Lungs of EpRas-Tet-On-ILEI #17 mice with and without Dox induction. 
 
It is clearly visible that the difference in tumor growth is mirrored in the difference in lung 
colonisation. The lung without Dox treatment is free of metastases while the lung with Dox 
treatment was overgrown with partially huge metastases. This was the result of a first pilot 
experiment. In order to do statistical analysis of the effect of ILEI interaction on lung 
colonisation, a higher number of mice need to be included. However, such an experiment was 
outside the time frame of my diploma thesis. 
 
 
0,0
0,1
0,2
0,3
0,4
0,5
0,6
0,7
0,8
EpRas-Tet-On-ILEI
#17
T
um
ou
r 
m
as
s 
(g
) 
af
te
r 
3
0
 d
ay
s 
of
 i
nj
ec
ti
on
- Dox
+ Dox
p < 0,01 
EpRas-Tet-On-ILEI #17 
- Dox + Dox 
RESULTS _______________________________________________________________________________________________________________ 
________________________________________________________________________ 
73 
3.2.3 Histological analysis of exgrafted tumors 
To see if there were different ILEI levels in the induced tumors in comparison to the uninduced 
ones we performed ILEI stainings (FIGURE 45 and 46).  
 
 
FIGURE 45 │ ILEI staining of EpC40-Tet-On-ILEI clones #20 and #40 tumors with and without Dox 
induction.  
 Red dots mark ILEI nuclei (blue) are the counterstainined with Hematoxylin.  
 
 
FIGURE 46 │ ILEI staining of EpRas-Tet-On-ILEI clones #16 and #17 tumors with and without Dox 
induction.  
 Red dots mark ILEI nuclei (blue) are the counterstainined with Hematoxylin.  
 
The tumors from mice receiving Dox in their drinking water clearly showed elevated ILEI 
expression.  
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The next questions were: (i) What is the reason for the increased tumor growth rates and (ii) 
how did ILEI caused this increased tumor growth. 
 
To test whether the size differences in tumors with or without Dox induction were due to 
alterations in apoptosis rates, all tumors were subjected to immunohistochemical staining for 
activated caspase 3 (FIGURE 64 and 65 APPENDIX). There were no significant differences in 
EpC40-Tet-On-ILEI and EpRas-Tet-On-ILEI tumors concerning apoptosis between Dox-induced 
and uninduced tumors. 
 
Similarly, the proliferation of different tumors with and without Dox induction was checked 
using immunohistochemical (IHC) stainings for the proliferations marker Ki67. IHC stainings for 
the EpC40-Tet-On-ILEI clones #20 and #40 with and without Dox induction (FIGURE 47 and 
49). For quantification, several stainings were counted and the percentage of Ki67 stained nuclei 
over the total number of nuclei was calculated (FIGURE 48 and 50).  
 
 
FIGURE 47 │ Ki67 IHC staining of EpC40-Tet-On-ILEI clones #20 and #40 tumors with and without Dox 
treatment.  
 Ki67 IHC staining (brown) marks proliferating nuclei, Hematoxylin contra staining (blue) labels all 
nuclei,  
 
0
5
10
15
20
25
30
35
40
45
50
55
EpRas-Tet-On-ILEI #20
%
 o
f 
K
i6
7
 p
os
it
iv
e 
nu
cl
ei
- Dox
+ Dox
0
5
10
15
20
25
30
35
40
45
EpRas-Tet-On-ILEI #40
%
 o
f 
K
i6
7
 p
os
it
iv
e 
nu
cl
ei
- Dox
+ Dox
 
FIGURE 48 │ Frequency of Ki67 positive nuclei from tumors induced by EpC40-Tet-On-ILEI clones #20 and 
#40, with and without Dox application to the mice. 
- Dox 
+ Dox 
EpC40-Tet-On-ILEI #20 EpC40-Tet-On-ILEI #40 
RESULTS _______________________________________________________________________________________________________________ 
________________________________________________________________________ 
75 
The total number of nuclei (Ki76 stained and unstained) served as 100% for calculations. The error 
was calculated with standard deviation (SD). 
 
 
FIGURE 49 │ Ki67 IHC staining of EpRas-Tet-On-ILEI clones #16 and #17 tumors with and without Dox 
treatment.  
 Ki67 IHC stainings (brown) marks proliferating nuclei, Hematoxylin contra staining (blue) labels all 
nuclei,  
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FIGURE 50 │ Frequency of Ki67 positive nuclei from tumors induced by EpRas-Tet-On-ILEI clones #16 and 
#17, with and without Dox application to the mice. 
The total number of nuclei (Ki76 stained and unstained) served as 100% for calculations. The error 
was calculated with standard deviation (SD). 
 
In summary, there was no difference in proliferation between Dox induced an uninduced tumors. 
These findings indicate that the ILEI induced increased tumorigenic capacity of the cells is not 
a consequence of elevated apoptosis protection or proliferation rate.  
 
Hematoxylin and Eosin stainings were performed as well (FIGURE 66 and 67 APPENDIX). 
Hematoxilin stained DNA (purple) and Eosin is for visualising soft tissue (pink).  
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3.3 Translational control of ILEI  
 
3.3.1 Regulatory motives in the 5´-UTR of ILEI 
The aim of these experiments was to find out, how translational regulation of the ILEI gene 
occurred. Below, the sequence of the predicted, long 5´-UTR is shown. This 5´-UTR of ILEI 
there is an alternative start codon (CTG) at nucleotide position 43 (FIGURE 51). The uORF 
starting from this CTG ends before the real start codon (AUG) and ORF begin. If the uORF 
would be translated the resulting peptide would be 42 amino acids in length. Secondary structure 
prediction by the program mfold (FIGURE 52) indicated that the alternative start codon might be 
accessible because it is localized in a loop region.  
 
1         CCACGCGTCCGCCCACGCGTCCGGGGAGGAGGCCTGGGGCGAGCTGGCTTCCTCCTCGGC 
1          P  R  V  R  P  R  V  R  G  G  G  L  G  R  A  G  F  L  L  G  
1           H  A  S  A  H  A  S  G  E  E  A  W  G  E  L  A  S  S  S  A 
1            T  R  P  P  T  R  P  G  R  R  P  G  A  S  W  L  P  P  R   
 
61        GCGGGCGGGCGCGCGGCGAAGCCGGAGGAGCCGGGGAAAGCCGAGGCGCGATCGGCGCGC 
21         A  G  G  R  A  A  K  P  E  E  P  G  K  A  E  A  R  S  A  R   
21          R  A  G  A  R  R  S  R  R  S  R  G  K  P  R  R  D  R  R  A  
20        R  G  R  A  R  G  E  A  G  G  A  G  E  S  R  G  A  I  G  A    
 
121       TCGGGAGGAGGCGGCGGCGGTGGCACCTCCCGTCGGCCTCCGACAGGACTGACGGCGGCG 
41         S  G  G  G  G  G  G  G  T  S  R  R  P  P  T  G  L  T  A  A   
41          R  E  E  A  A  A  V  A  P  P  V  G  L  R  Q  D  *  R  R  R  
40        L  G  R  R  R  R  R  W  H  L  P  S  A  S  D  R  T  D  G  G    
 
181       CGACCGCAGACGGGACCTTCTTTTGGAGACGTGCTAGAGAGTGAGAAGGCAAAAATGA 
61         R  P  Q  T  G  P  S  F  G  D  V  L  E  S  E  K  A  K  M      
61          D  R  R  R  D  L  L  L  E  T  C  *  R  V  R  R  Q  K  *     
60        A  T  A  D  G  T  F  F  W  R  R  A  R  E  *  E  G  K  N       
FIGURE 51 │ uORFs of the murine ILEI 5´-UTR with two alternative start codons CTG.  
In blue the uORF is marked and in green the start codon AUG. The bold asterisk labels distinguish the 
end of the uORF.  
 
 
FIGURE 52 │ Secondary structure prediction of 5´-UTR of murine ILEI with mfold.  
In blue circle the uORF start codon CUG is marked and in green circle the start codon AUG from the 
ORF.  
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RegRNA predicted two regulatory motives in the 5´-UTR, a terminal oligo-pyrimidine (TOP) 
element and an IRES site (FIGURE 53). Till now, TOP elements have been experimentally shown 
only in mRNAs coding for ribosomal proteins and transitional regulatory proteins. Some 
exploration of the predicted TOP elements in the ILEI 5´-UTR still needs to be found. The 
predicted IRES site could have some translational effect on the ILEI gene but no experiments 
have been done in this direction (FIGURE 54).  
 
 
FIGURE 53 │ Prediction of regulatory elements in the ILEI 5´-UTR using RegRNA.  
 
 
 
FIGURE 54 │ Prediction of the murine ILEI IRES in the 5´-UTR with RegRNA.  
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3.3.2 Regulatory motives in the 3´-UTR of ILEI 
Two forms of the ILEI 3´-UTR have been found, which divide the 3´-UTR in a long and a short 
version. This is the result of an alternative poly(A) signal (FIGURE 55 top panel) located in the 
3´-UTR, which has been confirmed by the findings of J. H. Jr. Greinwalds group (see chapter 
1.12 and (Pilipenko VV, 2004)). The existence of two different ILEI mRNA isoforms raised the 
question to what extent the two mRNAs are involved in the translational control of ILEI. 
 
There are nine predicted GAIT elements in the ILEI 3´-UTR (FIGURE 55 bottom panel and 
FIGURE 56) but only the one marked with the arrow head is predicted in all secondary structure 
calculations by mfold, indicating a high probability for the formation and stability of this stem-
loop structure. No functional studies were done of this predicted structure.  
 
FIGURE 55 │ Prediction of regulatory elements in the ILEI 3´-UTR with RegRNA.  
 
 
FIGURE 56 │ Left side: putative ILEI GAIT prediction with RegRNA.  
Right side: Consensus sequence of the secondary structure of GAIT elements (Ray PS, 2007). 
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3.3.3 Characterisation of the translation rate of the two ILEI 3´-UTR isoforms  
Initial data using RT-PCR showed that low ILEI expressing EpRas cells and high ILEI expressing 
EpRasXT cells have no difference in the abundance of ILEI mRNA. However, this assay did not 
distinguish between short and long ILEI mRNA forms (Waerner T, 2006). To examine if 
different ILEI protein levels correlate with a difference in the relative abundance of long 
versus short ILEI mRNA Northern blot analysis with four cell lines was performed (FIGURE 57). 
These four cell lines have naturally unequal intrinsic ILEI levels. The epithelial NMuMG, EpH4 
and EpRas cell lines have low amounts of ILEI and the fibroblastoid EpRasXT cell line expresses 
considerably higher amounts of the ILEI protein. NMuMG cells are normal murine mammary 
gland cells, often used as an in vitro model for EMT related questions, since similarly to EpRas 
cells they undergo TGFβ dependent EMT. 
 
 
FIGURE 57 │ The two isoforms of 3´-UTRs in different cell lines.  
 
There was no difference in the relative abundance of one of the two mRNA isoforms in cells 
with different ILEI protein levels.  
 
Next, we tried to determine if the translation rate of the two isoforms is different upon TGFβ 
induction by analysing the distribution of ILEI mRNA isoforms on polysomes. Sucrose gradient 
ultracentrifugation was applied to fractionate the total mRNA into polysome bound and free 
mRNA (FIGURE 58). To check if the mRNA was not degraded and the RNA was fractionated 
properly a chip analysis was run.  
 
 
FIGURE 58 │ RNA nano chip.  
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The 18S rRNA is a subunit of the 40S ribosome and the 28S and 5S RNA are subunits of the 
60S ribosome. They were used as markers for their corresponding subunits In the first eight 
fractions are free mRNA because not all ribosomal subunits are present. From fraction nine on 
there are actively translated mRNAs found because all components are present to build an intact 
ribosome. After sucrose gradient fractionation RNA was isolated and Northern blot analysis was 
used to separate the two isoforms based on their different running velocities in an agarose gel 
(FIGURE 59). Obviously, the later an mRNA appears in the sucrose gradient fractions, the higher 
number of ribosomes is bound the transcript ending up in polysome bound mRNA fractions 
(FIGURE 60). To detect both isoforms an ILEI probe for ILEI ORF was used.  
 
 
 
FIGURE 59 │ Northern blot analysis of ILEI on RNA fractions of a sucrose gradient. 
Top panel without TGFβ treatment, bottom panel with TGFβ treatment. Autoradiogram was generated 
using a Phosphoimager. Quantification was performed using IMAGEquant. Black boxes mark the 
quantified regions for long and short ILEI mRNA of the different fractions.  
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FIGURE 60 │ NMuMG cell fractions on sucrose gradient. 
Top panel without TGFβ treatment, bottom panel with TGFβ treatment.  
 
Northern blot analysis showed a shift from free mRNA to bound mRNA when the cells were 
treated with TGFβ. This shift was most apparent within the polysome bound fraction of the 
short ILEI mRNA (TABLE 4). This means, that more ILEI mRNA was translated and so higher 
amounts of ILEI protein were produced in the TGFβ treated cells. In conclusion, this experiment 
shows that all the important regulatory elements of translational control were present in the 
short mRNA, thus in the first part of the 3´-UTR or in the 5´-UTR. What the 3´-UTR long is 
doing when treated with TGFβ is hard to detect so no conclusions can be drawn from these few 
experiments.  
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ILEI mRNA short 
   - TGFβ  + TGFβ 
% free RNA 42,9 38,8 
% bound RNA 57,1 61,2 
% monosome bound RNA 17,5 15,6 
% oligosome bound RNA 27,1 22,1 
% polysome bound RNA 12,5 23,4 
TABLE 4 │ Comparison oft the 3´-UTR short levels in TGFβ treated and untreated cells.  
The free- and bound RNA are combined the total amount of RNA. Monosome-, oligosome- and 
polysome RNA combined make the bound RNA fraction.  
 
3.3.4 Evaluation of the importance of different UTR regions 
To evaluate in which UTR part the important regulatory regions are, seven UTR-FFL constructs 
were cloned using the pGL3-Control-MCS FFL reporter vector. The construct referred to as 5´ 
carried the 5´-UTR in front of the FFL sequence. The vector called 3´short and 3´long carried 
insertions of the two different 3´-UTR isoforms inserted directly after the STOP codon of the 
FFL. The two vectors called 5´+ 3´ short and 5´+ 3´ long had the 5´-UTR in front of the FFL 
and the short or the long 3´-UTR after the FFL coding sequence, respectively. As a positive 
reference the pGL3-Control-MCS vector (MSC) without any ILEI UTR inserts was used, whereas 
the pGL3-Enhancer vector (Enhancer) lacking the SV40 promotor served as negative control in 
the luciferase reporter assay (FIGURE 61).  
 
 
FIGURE 61 │ Different UTR-FFL regulator constructs.  
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(FIGURE 62). Since EpRasXT cells already have an autocrine TGFβ loop, treatment with exogenous 
TGFβ was not necessary.  
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FIGURE 62 │ FFL assay with different UTR constructs.  
 
Only the 5´-UTR-FFL construct shows a significant difference in expression between EpRas and 
EpRasXT. With the other constructs, no clear differences were detectable, thus further 
experiments were clearly necessary. A very significant, six-fold increase of FFL activity was 
detected using the EpRasXT cells. 3´-UTR short and long constructs showed at least a 50% 
decrease in expression compared to the MSC control. Interestingly, constructs in which both 
the 5´-UTR and 3´-UTR of ILEI were present (5´+3´-UTR short and 5´+3´-UTR long) the 
inhibitory effect of the 3´-UTRs overcome the activating effect of the 5´-UTR resulting in an 
inhibition of expression.  
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4 DISCUSSION  
 
 
A common way to study gene function in vitro and in vivo is to generate stable cell lines with 
altered levels of gene expression. However, these systems have the risk to select for clonal 
effects. In addition, primary effects often can not be set apart from downstream events or 
might be masked by compensatory mechanisms.  
Choosing an inducible system for the manipulation of gene expression level can avoid all this 
problems. Furthermore, this approach makes it possible to investigate the kinetics of cellular 
responses after the induction of gene over-expression or knock down. 
Although there are some inducible tumor cell lines available to study EMT, there is not a 
comprehensive model system which would allow studying several stages of tumor formation and 
progression. The cell lines of our choice provide three different aspects of tumor formation; the 
non-tumorigenic EpH4 cells, the EpC40 cells which form tumors but are unable to spread and 
metastasise and the EpRas cells which can form tumors and metastases.  
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4.1 TetR clones 
 
A 2-step approach was taken for cloning the inducible ILEI system. First, a general tool for 
tumor biology studies (TetR cells) was established, which enables to analyse gene function of any 
gene of interest in vitro and in vivo in an inducible manner. In a second step, these TetR clones 
from EpH4, EpC40 and EpRas, that were selected for good inducibility of the regulatory vector, 
can be further transfected with the expression vector, in which a variety of genes can be 
inserted. This way, a broad assortment of genes can be studied in a series of cell lines which 
represent three stages of tumorigenisis non-tumorigenic (EpH4), tumorigenic but non-metastatic 
(EpC40) and metastatic (EpRas) cells.  
 
For generating the inducible clones the T-Rex system from Invitrogen was used. According to 
the manufacturers on clone out of twenty should have a proper induction capability. Our 
experiments did not reflect these predictions. The average calculated from the transfection of 
3 cell lines showed that approximately 50 clones had to be tested to find one with an induction 
capability over two-fold, and fare more clones needed to be analysed to find some with higher 
induction capabilities.  
 
A very important criteria in the validation of the generated inducible TetR clones is that the 
introduction of the regulatory vector into the cells does not alter the original characteristics of 
the cell lines. To test this, several in vitro comparative assays were done between the parental 
cell lines and the TetR clones. In all in vitro test we performed the TetR clones behaved exactly 
like the parental cells. The morphology of all three TetR clones on plastic was identical to their 
parental cells. In collagen gels the phenotype with and without TGFβ treatment was equal 
between parental cell lines and the selected TetR clones. Stainings of these collagen gels were 
done for E-cadherin and vimentin, two key markers for the distinguish between epithelial cells 
before and mesenchymal cells after EMT. In all cases the inspected TetR clones showed a 
similar marker expression as their parental counterparts. This lead to the conclusion that the 
generated clones behaved in vitro similar as the parental cell lines.  
 
The in vivo tests, designed to detect possible differences between parental cells and TetR 
clones consisted tests for tumor growth rate, survival/apoptosis assays and assays for lung 
metastases (colonisation). EpH4-TetR clones as well as their parental counterparts did not form 
tumors upon mammary gland fat pad injections. This result was expected since these EpH4-
derived clones should be non tumorigenic cells. In case of EpC40-TetR and the parental EpC40 
cells, the tumor growth was very slow in both cases in comparison to earlier experiments (FIGURE 
63) (Janda E, 2002b). In this earlier experiments two different EpC40 clones were tested 
EpC40-5 and EpC40-1b. For generation of the TetR clones the EpC40 clone 5 was used (EpC40-5 
is referred to as EpC40 throughout my thesis for simplicity) We used this clone since we 
reasoned that a slower tumor growth rate would make it easier to detect a possible tumor 
growth enhancement by ILEI. In the published studies, 100.000 cells were injected and after 29 
days the EpC40-5 tumors already had a diameter of 5mm. In our tumor growth assay we also 
injected 100.000 cells but after 30 days there were no tumors visible. More than 90 days were 
required that tumors reached a size of about 5mm in diameter. This shows that in our 
examinations the EpC40-5 clone grows only one third as fast as it did in the original 
experiments.  
 
The growth of the EpRas-TetR clone and the parental EpRas cells after mammary fat pad 
injections showed distinct differences. The parental EpRas cells formed tumors with comparable 
size in half the time as the EpRas-TetR clone (FIGURE 28). This slower tumor growth of EpRas-
TetR might be a characteristics of the selected subclone. This particular EpRas-TetR clone 
showed higher sensitivity for TGFβ than other tested clones. In collagen gels, at a dosage of 
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10ng/ml TGFβ the first apoptotic structures appeared despite the cells were undergoing TGFβ 
induced EMT. This behaviour might reflect a lower expression level of Ras V12, which was not 
investigated in detail. The observed slower tumor growth of EpRas-TetR was favourable because 
a slow growth is a better basis to monitor the effect of a factor with a potential tumor 
promoting role. The same manner of slow growth was found when the survival rate of nude mice 
was charted after intravenously injecting cells into the tail vain. Parental EpRas cells killed the 
mice less than half the time then the EpRas-TetR did (FIGURE 30). This observation correlated 
with the slower growth rate of the TetR tumors compared to the parental cells. EpC40 as well as 
EpC40-TetR cells failed to develop lung metastases after tail vain injections which is was 
consistent with several other experiments (Janda E, 2002b).  
 
 
FIGURE 63 │ Tumor growth of EpC40 and other cells in nude mice (Janda E, 2002b).  
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4.2 ILEI inducible clones 
 
The second step towards the ILEI inducible clones was to transfect the cells with the Tet-On-
ILEI construct. The odds of finding one proper inducible clone was less than 14:1 rendering the 
selection procedure by Western blot quite time-consuming. In future experiments, this problem 
could be overcome by cloning an IRES-GFP behind the gene of interest so that one could FACS 
sort for highly inducible clones. The problem with the clones obtained was that they were only 
weakly inducible (FIGURES 32 to 34). One or two inducible ILEI expressing clones were found for 
all three cell lines, however none of these clones showed such a high inducibility as the original 
TetR clones after the first step. This indicates that either cells might contradict against high 
ILEI levels or that simply even a higher number of clones should have been tested in order to 
find good inducibility. This is a common draw-back of strategies of random insertion, where the 
undesired influence of flanking genomic sequences is not predictable.  
 
EpC40-Tet-On-ILEI clone #20 had low levels of ILEI in general but when induced with Dox, the 
ILEI level was higher, predominantly in the supernatant. The EpC40-Tet-On-ILEI clone #40 had 
generally higher ILEI levels with or without induction then clone #20 but when induced, both 
the secreted and intracellular ILEI level were more significantly elevated. To test the effect of 
different induced ILEI levels in vivo, mammary gland fat pad injections were done. In EpC40-
Tet-On-ILEI clone #20 as well as in clone #40 were no eminent differences in tumor size or 
weight between the uninduced and the induced setup. It has to be mentioned that the EpC40-
Tet-On-ILEI clone #20, which had the lower basal ILEI levels showed at least a tendency that 
the Dox induction resulted in bigger, heavier tumors.  
In previous experiments of the Beug group, the analysis of tumor formation by stable over-
expressing EpC40-ILEI cells and control EpC40 cells revealed that ILEI strongly enhanced 
tumor size (3.6-fold increase in mean tumor weight per mouse). Stable ILEI over-expressing 
EpC40 cells were tested for metastatic behaviour by tail vein injection of nude mice, in 
comparison to respective control cells. ILEI expression induced strong metastatic capacity in 
the tumorigenic but nonmetastatic EpC40 cells (Waerner T, 2006). The tumor growth and lung 
metastases results could not be reproduced in this fashion with the inducible EpC40-Tet-On-
ILEI clones.  
 
EpRas-Tet-On-ILEI clone #16 had a high basal ILEI level, but nevertheless showed nicely 
elevated ILEI levels upon expression with Dox both intracellularly and in the supernatant. The 
EpRas-Tet-On-ILEI clone #17 had a lower ILEI expression without induction, than the clone 
#16 but a preliminary high inducibility (FIGURE 43). When fat pad injections were done using 
these two clones with and without Dox induction the differences in basal ILEI levels might 
explain the diverse results. The clone #16, which had generally higher basal ILEI levels showed 
no considerable difference in tumor mass or tumor volume with or without Dox (FIGURE 42 and 
43). In case of the EpRas-Tet-On-ILEI clone #17 the basic ILEI level was much lower then of 
clone #16 and tumor growth of this clone was significant slower then of clone #16. Upon Dox 
induction, which resulted in higher ILEI levels, tumor mass and volume were significantly 
increased and become comparable with the growth rate of clone #16. This data might indicate a 
dose dependent effect of ILEI on tumor growth. However, this does not explain why a further 
elevation of ILEI in clone #16 did not result an even higher tumor growth rate. We can only 
speculate that those levels are above the saturation level of the ILEI receptors expressed in 
the tumor tissue and therefore could not have any additional effects.  
 
The assay for metastatic behaviour, the lung colonisation assay, was performed only with EpRas-
Tet-On-ILEI clone #17. There was a major discrepancy between the lungs of mice suppliede or 
not supplied with Dox in the drinking water (FIGURE 44). The lung without Dox treatment were 
free of metastases at the timepoint of dissection while the lung with Dox treatment was 
DISCUSSION _______________________________________________________________________________________________________________ 
________________________________________________________________________ 
88 
overgrown with partially huge metastases. Thus, the difference in tumor growth was mirrored in 
the difference in lung colonisation, which was mirrored in the difference in ILEI expression 
levels. This was the result of a first pilot experiment. In order to do statistical analysis on the 
effect of ILEI induction on lung colonisation, a higher number of mice need to be included. 
 
To analyze, whether ILEI induces EMT in these tumors, we used established procedures to 
compare EpC40 and EpC40 stable over-expressing ILEI tumors by IHC. In those studies, serial 
tumor sections were stained for E-cadherin, vimentin, and ILEI expression. The outcome was 
that EpC40-derived tumors showed strong, membrane-localized E-cadherin expression, while 
vimentin staining was predominantly detected in only areas presumably representing the stroma. 
In contrast, the ILEI-positive cells in the EpC40 stable over-expressing ILEI tumors showed no 
or weak cytoplasmic E-cadherin staining but strong vimentin expression (Waerner T, 2006).  
Due to a lack of time, the inducible ILEI over-expressing tumors were IHC stained only for 
ILEI. The result was that the Dox induced tumors had a stronger ILEI staining than the 
uninduced ones but the difference was not extremely pronounced. For further examination of 
this topic it would be sensible to tag ILEI in the transfected cells so that the ILEI and induced 
ILEI could be distinguishable. 
 
In previous experiments on porous supports (filters, still supporting complete epithelial polarity), 
stable ILEI over-expression induced complete EMT (Waerner T, 2006). In our experiments 
regarding this issue we took the Tet-On-ILEI clones from EpH4, EpC40 and EpRas and 
cultivated them for eight days on filters. Regardless if induced with Dox or not the morphology 
of the cells was unchanged and remained epithelial (FIGURE 38). No EMT was induced. An 
explanation might be that the inducible clones have lower ILEI levels and the threshold for 
inducing EMT was not reached.  
 
In collagen gels, all EpH4, EpC40 and EpRas cells stable over-expressing ILEI underwent 
complete EMT, forming unordered structures of fibroblastoid cells expressing vimentin but not 
E-cadherin (Waerner T, 2006). Our experiments with EpH4-Tet-On-ILEI, EpC40-Tet-On-ILEI 
and EpRas-Tet-On-ILEI cells in collagen gels showed no EMT when treated with Dox. If TGFβ 
was added, cells underwent their typical programmes accordingly (EpH4-Tet-On-ILEI cells died, 
EpC40-Tet-On-ILEI cells underwent scattering and EpRas-Tet-On-ILEI cells underwent EMT) 
but no differences at all were visible between Dox induced and uninduced cells. After the cells 
responded to TGFβ, treatment was stopped. The withdrawal in EpC40-Tet-On-ILEI cells showed 
that the uninduced cells reverted to more compact and rounder structures while the Dox 
induced cells maintained their spiky phenotype (FIGURE 39). In conclusion ILEI is not able to 
induce EMT in the inducible clones, for that TGFβ is necessary. Nevertheless ILEI is able to 
maintain the TGFβ induced mesenchymal phenotype in EpC40 cells.  
 
For all tested clones in all three cell lines including the Tet-On-Empty control clones it was true 
that the uninduced cells grow a bit faster then the ones treated with Dox. However, this 
difference was not significant. This indicates, that high Dox concentration might have a slight 
inhibitory effect, but ILEI had definitely no effect on cell proliferation. Also in IHC of tumor 
sections for the proliferation marker Ki67, there was no difference in proliferation between 
Dox induced and uninduced tumors. These findings confirm the in vitro growth curve 
experiments, telling that the ILEI induced increased tumorigenic capacity of the cells is not a 
consequence of elevated proliferation rate in vitro and in vivo.  
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4.3 Translational control of ILEI 
 
Translational control is to a big part carried out by structural- and sequential elements in the 5- 
and 3´-UTR of a gene. For the well established structural elements, predictions were made for 
ILRI mRNA using the programmes RegRNA and mfold. It was not possible to investigate any of 
the predicted elements in experiments during the time course of my diploma thesis.  
 
In the 5´-UTR an IRES motive and a TOP sequence were found (FIGURE 53). To test if this 
predicted IRES actually induces translation, one would have to perform biscistronic reporter 
assays. In this type of assays, IRES is located between two reporter open reading frames in a 
eukaryotic mRNA, so IRES can drive translation of the downstream protein coding region 
independently of the 5'-cap structure.  
 
The RegRNA prediction showed four TOP sequence elements in the ILEI 5´-UTR. Till now, TOP 
element has been experimentally shown only mRNA coding for ribosomal- and transitional 
regulatory proteins. Some exploration of the predicted TOP elements in the unusual context of 
the ILEI 5´-UTR could reveal new regional sites and functions.  
 
The in silico analysis of the 3´-UTR identified an alternative poly(A) site and a GAIT element 
(FIGURE 55).  
The alternative poly(A) signal of the ILEI 3´-UTR was proposed by the group of J. H. Jr. 
Greinwalds (Pilipenko VV, 2004). We could confirm the existence of a short and a long ILEI 
mRNA form by Northern blot analysis.  
 
From the predicted nine GAIT elements in the ILEI 3´-UTR it is safe to assume that one of 
them has a high probability of forming. This one secondary structure is in all calculations with 
RegRNA equivalent. The ILEI GAIT has the same structure (proximal stem – asymmetric bulge – 
distal stem – terminal loop) as the consensus sequence motive dictates and also both of the 
invariant nucleotides are present. Experiments to determine the exact influence of the GAIT 
element on the ILEI mRNA were not done.  
 
The reporter assay with firefly and Renilla was made to inspect in which part of the ILEI UTR 
the important regulatory regions are. For this tests EpRas and EpRasXT cells were used because 
EpRasXT cells already have an autocrine TGFβ loop so that extrinsic TGFβ treatment was not 
necessary in order to get cells with high and low TGFβ levels.  
The results of the FFL Renilla coupled reporter assays showed that there is a significant 
difference in EpRas and EpRasXT cells when the 5´-UTR-FFL construct is transfected. In case 
of all other constructs there was no difference in fluorescence. The interesting thing is that the 
constructs long or short 3´-UTR in combination with the 5´-UTR showed no difference. One 
explanation for this discrepancy could be that the 3´-UTR influences the 5´-UTR and renders it 
inactive. A second explanation could be that the different secondary structures of ILEI mRNA 
and the FFL 5´-3´-ILEI constructs UTR influence the effectiveness of the regulatory capacity 
of the 5´-UTR.  
The reporter tests only provide data on protein level. As next step it would be sensible to 
explore the different constructs in q-RT-PCR to assess if the observed effect is exclusively 
translational.  
 
It has been shown before by semiquantitative RT-PCR that polysome bound, but not total ILEI 
mRNA, is strongly up regulated in mesenchymal EpRasXT cells when compared to epithelial EpRas 
cells, clearly showing translational control of ILEI expression (Waerner T, 2006). In conclusion 
with this we also detected a shift from free ILEI mRNA to bound RNA in Northern blot analysis 
after sucrose gradient RNA fractionation of NMuMG cells treated with TGFβ (FIGURE 59 and 
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60). This shift was apparent most within the polysome bound fraction of the short ILEI mRNA 
(TABLE 4). It means that more ILEI mRNA was translated and so higher amounts of ILEI protein 
were produced in the TGFβ treated cells. In conclusion, this experiment shows that important 
regulatory elements of translational control are present in the short mRNA, thus in the first 
part of the 3´-UTR or in the 5´-UTR. From this experiment it is not possible to conclude 
something about the polysome bound amounts of the 3´-UTR long with or without TGFβ 
treatment because the detection was poor.  
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APPENDIX 
 
 
 
FIGURE 64 │ Immunohistochemical stainings for activated caspase 3 (red) of EpC40-Tet-On-ILEI tumors #20 
and #40. 
 
 
 
FIGURE 65 │ Immunohistochemical stainings for activated caspase 3 (red) of EpRas-Tet-On-ILEI tumors #16 
and #17. 
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FIGURE 66 │ Immunohistochemical stainings for Hematoxilin (purple) and Eosin (pink) of EpC40-Tet-On-ILEI 
tumors #20 and #40. 
 
 
 
FIGURE 67 │ Immunohistochemical stainings for Hematoxilin (purple) and Eosin (pink) of EpRas-Tet-On-ILEI 
tumors #16 and #17. 
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